data_2mbd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mbd _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 119.129 -0.463 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.429 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.554 1.098 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.214 -0.422 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 119.331 -0.366 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.051 -0.419 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.73 153.37 85.24 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.151 0.981 . . . . 0.0 111.852 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.16 149.36 87.12 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.088 0.955 . . . . 0.0 112.1 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt -135.57 149.83 70.37 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.31 147.63 93.15 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.285 1.034 . . . . 0.0 111.259 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.05 154.32 92.44 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.172 0.989 . . . . 0.0 111.835 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.13 151.06 90.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.25 1.02 . . . . 0.0 111.28 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.18 152.25 86.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.072 0.949 . . . . 0.0 111.798 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.25 142.8 92.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.294 1.038 . . . . 0.0 111.6 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.47 145.43 92.9 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.196 0.998 . . . . 0.0 111.595 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt -137.11 151.06 71.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.707 1.603 . . . . 0.0 111.492 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.09 143.8 81.07 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.053 0.941 . . . . 0.0 111.72 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.592 0.551 . . . . 0.0 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.2 153.88 82.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 129.241 3.016 . . . . 0.0 112.638 -1.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 145.48 84.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.093 0.957 . . . . 0.0 111.944 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 150.61 73.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.652 1.581 . . . . 0.0 111.269 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.02 152.17 92.81 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.267 1.027 . . . . 0.0 111.741 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.53 148.06 87.65 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.0 0.92 . . . . 0.0 112.216 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.441 0.467 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -133.12 151.1 77.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 130.699 3.6 . . . . 0.0 110.841 1.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.429 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt -136.34 151.66 73.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.682 1.593 . . . . 0.0 111.456 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 CA-C-O 121.639 0.577 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.87 147.99 63.56 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 129.224 3.01 . . . . 0.0 111.966 -1.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 CA-C-O 121.633 0.574 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.56 161.18 77.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 129.136 2.974 . . . . 0.0 112.415 -1.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.33 146.85 84.71 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.067 0.947 . . . . 0.0 111.625 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.36 144.04 86.29 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.201 1.0 . . . . 0.0 111.788 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.59 147.86 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.415 2.686 . . . . 0.0 115.253 -172.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.02 150.18 87.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.098 0.959 . . . . 0.0 112.277 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.31 147.64 85.48 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.068 0.947 . . . . 0.0 112.106 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt -73.32 147.45 87.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.113 0.965 . . . . 0.0 112.117 178.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.511 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt 54.85 142.27 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.108 1 C-N-CA 133.824 4.85 . . . . 0.0 116.312 12.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.44 150.03 86.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.077 0.951 . . . . 0.0 112.055 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.83 151.4 75.61 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.861 1.664 . . . . 0.0 111.338 178.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt 61.58 149.45 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 128.437 2.695 . . . . 0.0 115.534 -172.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.09 156.0 80.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.878 1.671 . . . . 0.0 111.038 178.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.37 140.63 87.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.201 1.001 . . . . 0.0 111.087 178.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.81 151.81 93.23 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.346 1.059 . . . . 0.0 111.754 178.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.3 138.55 86.79 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.222 1.009 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.09 146.19 86.92 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.087 0.955 . . . . 0.0 112.081 178.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.14 145.2 85.67 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 112.058 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.46 147.61 66.6 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.88 1.672 . . . . 0.0 110.738 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.43 153.74 85.83 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.121 0.969 . . . . 0.0 111.941 177.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.97 141.93 78.94 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.979 0.912 . . . . 0.0 111.561 178.329 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.13 149.59 89.58 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.982 0.913 . . . . 0.0 112.42 178.15 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.45 157.34 84.66 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.086 0.954 . . . . 0.0 112.444 177.816 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 145.41 85.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.114 0.965 . . . . 0.0 112.148 178.241 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.26 144.61 84.63 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.997 0.919 . . . . 0.0 111.976 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp 62.32 149.78 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 128.206 2.602 . . . . 0.0 114.664 -173.041 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.13 144.2 92.28 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 111.619 178.901 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.15 145.56 86.05 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.008 0.923 . . . . 0.0 112.148 178.447 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt 61.71 147.29 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 128.425 2.69 . . . . 0.0 115.318 -173.008 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 121.695 0.608 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.78 150.25 72.19 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 129.181 2.993 . . . . 0.0 112.471 -1.377 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 119.129 -0.463 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.554 1.098 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.214 -0.422 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 119.331 -0.366 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.051 -0.419 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.73 153.37 85.24 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.151 0.981 . . . . 0.0 111.852 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.16 149.36 87.12 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.088 0.955 . . . . 0.0 112.1 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt -135.57 149.83 70.37 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.31 147.63 93.15 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.285 1.034 . . . . 0.0 111.259 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.05 154.32 92.44 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.172 0.989 . . . . 0.0 111.835 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.13 151.06 90.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.25 1.02 . . . . 0.0 111.28 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.18 152.25 86.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.072 0.949 . . . . 0.0 111.798 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.25 142.8 92.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.294 1.038 . . . . 0.0 111.6 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.47 145.43 92.9 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.196 0.998 . . . . 0.0 111.595 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt -137.11 151.06 71.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.707 1.603 . . . . 0.0 111.492 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.09 143.8 81.07 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.053 0.941 . . . . 0.0 111.72 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.592 0.551 . . . . 0.0 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.2 153.88 82.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 129.241 3.016 . . . . 0.0 112.638 -1.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 145.48 84.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.093 0.957 . . . . 0.0 111.944 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 150.61 73.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.652 1.581 . . . . 0.0 111.269 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.02 152.17 92.81 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.267 1.027 . . . . 0.0 111.741 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.53 148.06 87.65 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.0 0.92 . . . . 0.0 112.216 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.441 0.467 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -133.12 151.1 77.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 130.699 3.6 . . . . 0.0 110.841 1.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt -136.34 151.66 73.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.682 1.593 . . . . 0.0 111.456 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 CA-C-O 121.639 0.577 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.87 147.99 63.56 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 129.224 3.01 . . . . 0.0 111.966 -1.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 CA-C-O 121.633 0.574 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.56 161.18 77.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 129.136 2.974 . . . . 0.0 112.415 -1.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.33 146.85 84.71 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.067 0.947 . . . . 0.0 111.625 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.36 144.04 86.29 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.201 1.0 . . . . 0.0 111.788 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.59 147.86 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.415 2.686 . . . . 0.0 115.253 -172.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.02 150.18 87.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.098 0.959 . . . . 0.0 112.277 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.31 147.64 85.48 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.068 0.947 . . . . 0.0 112.106 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt -73.32 147.45 87.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.113 0.965 . . . . 0.0 112.117 178.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.511 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt 54.85 142.27 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.108 1 C-N-CA 133.824 4.85 . . . . 0.0 116.312 12.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.44 150.03 86.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.077 0.951 . . . . 0.0 112.055 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.83 151.4 75.61 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.861 1.664 . . . . 0.0 111.338 178.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt 61.58 149.45 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 128.437 2.695 . . . . 0.0 115.534 -172.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.09 156.0 80.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.878 1.671 . . . . 0.0 111.038 178.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.37 140.63 87.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.201 1.001 . . . . 0.0 111.087 178.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.81 151.81 93.23 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.346 1.059 . . . . 0.0 111.754 178.627 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.3 138.55 86.79 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.222 1.009 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.09 146.19 86.92 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.087 0.955 . . . . 0.0 112.081 178.287 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.14 145.2 85.67 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 112.058 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.46 147.61 66.6 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.88 1.672 . . . . 0.0 110.738 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.43 153.74 85.83 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.121 0.969 . . . . 0.0 111.941 177.725 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.97 141.93 78.94 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.979 0.912 . . . . 0.0 111.561 178.329 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.13 149.59 89.58 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.982 0.913 . . . . 0.0 112.42 178.15 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.45 157.34 84.66 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.086 0.954 . . . . 0.0 112.444 177.816 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 145.41 85.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.114 0.965 . . . . 0.0 112.148 178.241 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.26 144.61 84.63 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.997 0.919 . . . . 0.0 111.976 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp 62.32 149.78 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 128.206 2.602 . . . . 0.0 114.664 -173.041 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.13 144.2 92.28 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 111.619 178.901 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.15 145.56 86.05 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.008 0.923 . . . . 0.0 112.148 178.447 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt 61.71 147.29 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 128.425 2.69 . . . . 0.0 115.318 -173.008 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 121.695 0.608 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.78 150.25 72.19 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 129.181 2.993 . . . . 0.0 112.471 -1.377 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.324 -0.37 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.549 0.908 0 CA-C-O 119.129 -0.463 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 119.296 -0.383 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 119.309 -0.377 . . . . 0.0 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.546 0.823 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.548 0.87 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.554 1.098 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.548 0.868 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 119.214 -0.422 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 119.331 -0.366 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.553 1.096 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.549 0.914 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.547 0.85 0 CA-C-O 119.007 -0.52 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-O 118.793 -0.622 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.548 0.873 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.051 -0.419 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.73 153.37 85.24 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.151 0.981 . . . . 0.0 111.852 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.64 153.07 74.32 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.919 2.413 . . . . 0.0 113.082 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.15 -31.99 71.71 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 113.113 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.94 -41.0 95.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.364 1.066 . . . . 0.0 112.456 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.98 -44.49 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.395 1.078 . . . . 0.0 110.059 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.57 -38.22 74.46 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.711 -0.618 . . . . 0.0 111.327 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 t -68.86 -30.94 69.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.84 -40.07 91.47 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.104 0.954 . . . . 0.0 110.711 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 61.7 mt -77.45 -45.52 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 126.485 1.914 . . . . 0.0 109.551 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.75 -50.58 70.02 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 112.124 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -73.44 -26.8 61.1 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.44 -40.98 66.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.232 1.013 . . . . 0.0 112.906 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -80.77 -19.37 45.0 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.821 1.248 . . . . 0.0 113.341 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.66 21.79 63.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.005 1.288 . . . . 0.0 114.319 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.1 92.17 3.53 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.124 1.37 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.0 t -131.17 125.43 33.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.818 2.047 . . . . 0.0 109.066 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -141.02 174.83 10.14 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.365 1.466 . . . . 0.0 111.289 -173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.41 140.38 46.27 Favored Glycine 0 N--CA 1.464 0.523 0 CA-C-N 119.399 0.999 . . . . 0.0 111.446 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -81.46 -15.49 32.09 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 118.209 1.005 . . . . 0.0 114.607 -2.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 26.1 tp -51.85 -40.1 59.98 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.197 1.399 . . . . 0.0 113.854 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -62.43 -41.27 98.59 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.261 1.424 . . . . 0.0 112.01 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -72.24 -42.92 65.12 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.934 1.293 . . . . 0.0 111.314 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.55 -46.09 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.365 1.466 . . . . 0.0 111.747 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -98.91 -11.17 21.91 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt 56.09 63.33 2.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.287 1.835 . . . . 0.0 111.918 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 94.1 m . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.124 175.112 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.16 149.36 87.12 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.088 0.955 . . . . 0.0 112.1 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.74 157.86 39.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.663 2.909 . . . . 0.0 111.875 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -55.91 -30.83 62.22 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -70.32 -24.26 62.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.43 -41.09 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.58 1.152 . . . . 0.0 110.403 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -56.59 -29.79 62.49 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.697 -0.627 . . . . 0.0 112.352 173.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -58.05 -37.92 75.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.452 1.101 . . . . 0.0 113.195 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.37 93.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.924 0.868 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.43 -42.16 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.935 1.694 . . . . 0.0 109.885 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.59 74.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.517 1.527 . . . . 0.0 112.453 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.2 -25.96 55.67 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -73.41 -39.72 64.84 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.296 0.953 . . . . 0.0 113.277 171.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.31 -15.42 40.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.214 1.406 . . . . 0.0 113.511 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.84 23.01 65.08 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.7 1.143 . . . . 0.0 114.48 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -127.83 100.36 5.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.277 1.431 . . . . 0.0 110.627 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.9 t -145.2 119.38 9.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.67 1.588 . . . . 0.0 110.07 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -150.87 171.35 17.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.209 1.004 . . . . 0.0 113.187 -166.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.75 -131.52 52.09 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.782 -1.01 . . . . 0.0 111.828 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.74 -32.74 46.3 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 CA-C-N 119.736 1.768 . . . . 0.0 112.213 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.5 tp -62.66 -36.46 82.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.663 1.12 . . . . 0.0 112.374 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -57.91 -40.53 80.61 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.778 1.231 . . . . 0.0 112.606 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.85 -44.45 49.03 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.13 0.972 . . . . 0.0 112.479 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.39 -39.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.28 1.432 . . . . 0.0 112.359 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.4 t -98.66 -9.13 25.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 112.816 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.07 73.64 0.22 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.959 2.503 . . . . 0.0 112.599 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.032 1.333 . . . . 0.0 111.981 178.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.2 mt -135.57 149.83 70.37 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.655 1.582 . . . . 0.0 111.36 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.17 154.2 56.97 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.282 2.655 . . . . 0.0 110.974 173.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -54.88 -34.96 63.58 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.671 1.189 . . . . 0.0 113.757 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -65.98 -20.67 66.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.766 1.226 . . . . 0.0 114.261 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.42 -47.2 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.105 1.362 . . . . 0.0 110.132 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.46 -26.54 67.95 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.296 1.039 . . . . 0.0 112.961 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.06 -43.79 91.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.512 1.125 . . . . 0.0 112.294 170.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.47 78.75 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.929 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.37 -49.95 81.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 110.854 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.87 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.541 1.136 . . . . 0.0 111.691 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.8 OUTLIER -67.0 -43.12 83.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.112 0.965 . . . . 0.0 113.003 178.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -71.31 -34.79 70.92 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.03 0.932 . . . . 0.0 113.297 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -82.29 -12.33 58.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.057 0.943 . . . . 0.0 113.405 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.29 22.91 74.86 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.098 0.856 . . . . 0.0 113.292 -171.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -114.38 67.08 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.737 2.015 . . . . 0.0 110.107 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.3 t -132.98 118.16 18.51 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.021 1.328 . . . . 0.0 111.246 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -147.24 167.4 24.32 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.926 1.69 . . . . 0.0 111.442 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.2 -131.26 48.4 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.323 0.963 . . . . 0.0 113.326 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -55.79 -37.7 95.33 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.056 2.504 . . . . 0.0 113.632 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.37 -40.75 96.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.32 0.964 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -67.19 -38.26 85.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.24 1.416 . . . . 0.0 112.209 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.83 -41.62 99.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.876 0.871 . . . . 0.0 111.782 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -71.5 -43.98 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.483 1.513 . . . . 0.0 112.155 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.42 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 17.7 t -105.07 1.28 28.34 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.521 1.528 . . . . 0.0 114.177 -165.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.353 0.0 OUTLIER 50.27 33.09 6.87 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 128.698 2.799 . . . . 0.0 115.204 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 64.4 m . . . . . 0 C--O 1.252 1.204 0 C-N-CA 127.032 2.133 . . . . 0.0 113.374 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.31 147.63 93.15 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.285 1.034 . . . . 0.0 111.259 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.87 150.57 87.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.015 2.477 . . . . 0.0 113.105 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.05 -34.85 73.97 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.476 -0.765 . . . . 0.0 113.064 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -69.85 -30.99 68.6 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.3 -50.77 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.18 0.992 . . . . 0.0 109.76 168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.72 -31.66 71.83 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.498 -0.751 . . . . 0.0 112.805 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.54 -40.34 86.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.447 1.099 . . . . 0.0 112.416 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.47 -42.39 74.91 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.465 -0.772 . . . . 0.0 111.324 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 mm -60.73 -48.2 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.415 1.086 . . . . 0.0 111.069 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -47.56 85.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.265 1.026 . . . . 0.0 112.573 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -79.86 -22.16 43.24 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -71.69 -39.42 70.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.772 1.229 . . . . 0.0 112.278 170.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -81.34 -19.24 43.21 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.64 1.176 . . . . 0.0 113.651 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.06 24.55 75.62 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.006 0.812 . . . . 0.0 113.286 -170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -116.85 71.71 0.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.053 2.141 . . . . 0.0 109.816 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -136.88 112.72 9.56 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.908 1.283 . . . . 0.0 111.163 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -144.6 165.06 29.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.81 1.644 . . . . 0.0 111.574 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.83 4.99 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.221 1.391 . . . . 0.0 113.488 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.53 -40.07 32.62 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.547 2.165 . . . . 0.0 112.431 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -39.31 93.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.076 1.307 . . . . 0.0 111.141 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -62.84 -46.59 87.22 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.894 1.278 . . . . 0.0 111.47 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 tt -59.59 -40.38 87.23 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.333 1.053 . . . . 0.0 112.638 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.94 -36.49 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.739 1.616 . . . . 0.0 113.137 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.8 t -107.6 -22.08 12.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.633 1.173 . . . . 0.0 112.848 -166.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? 55.02 114.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.665 2.786 . . . . 0.0 113.827 -155.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.549 1.54 . . . . 0.0 112.526 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.05 154.32 92.44 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.172 0.989 . . . . 0.0 111.835 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.69 149.38 87.8 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.084 2.523 . . . . 0.0 111.524 169.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -55.59 -33.89 64.34 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -170.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -62.91 -37.58 87.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.759 1.624 . . . . 0.0 113.581 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -83.89 -45.55 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.715 1.206 . . . . 0.0 109.558 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.5 tp -58.92 -28.23 66.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.955 1.302 . . . . 0.0 112.572 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.1 t -57.6 -39.36 76.67 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.278 1.431 . . . . 0.0 112.956 172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -44.4 69.74 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.011 -1.056 . . . . 0.0 111.062 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -60.74 -42.47 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.706 1.202 . . . . 0.0 111.139 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.21 80.32 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.937 1.295 . . . . 0.0 113.343 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 92.7 mttt -76.46 -46.68 25.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.538 1.135 . . . . 0.0 111.582 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -58.6 -34.81 71.53 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.721 1.209 . . . . 0.0 113.08 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -93.14 -10.98 33.99 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.525 1.53 . . . . 0.0 114.264 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 24.76 76.47 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 119.098 0.863 . . . . 0.0 113.849 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -94.88 -10.7 30.44 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.0 2.12 . . . . 0.0 113.474 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.4 t -70.25 109.48 4.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.158 0.983 . . . . 0.0 112.928 -170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -145.26 165.89 27.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.253 1.821 . . . . 0.0 111.554 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.6 -119.14 7.91 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 124.99 1.281 . . . . 0.0 113.434 172.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.62 -38.63 39.79 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.337 2.025 . . . . 0.0 112.465 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -39.49 92.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.836 1.198 . . . . 0.0 111.118 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -60.64 -41.55 95.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.108 1.363 . . . . 0.0 111.412 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.34 -39.22 81.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.052 0.941 . . . . 0.0 112.94 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.01 -38.81 76.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.416 1.486 . . . . 0.0 112.591 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 44.8 t -113.4 -12.62 12.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.112 1.365 . . . . 0.0 113.517 -161.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? 55.48 82.51 0.1 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.319 2.248 . . . . 0.0 112.228 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.8 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.173 1.789 . . . . 0.0 111.916 -174.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.978 -0.449 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.13 151.06 90.22 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.25 1.02 . . . . 0.0 111.28 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.07 148.6 91.41 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.883 2.389 . . . . 0.0 112.089 176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -53.96 -36.71 63.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.678 1.191 . . . . 0.0 113.273 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -57.32 -42.74 82.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.258 1.423 . . . . 0.0 112.928 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.21 -46.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.985 1.314 . . . . 0.0 109.532 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.72 -27.04 68.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.259 1.024 . . . . 0.0 112.619 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 t -55.78 -38.0 69.32 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.038 1.335 . . . . 0.0 112.94 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.03 -50.92 66.53 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.854 0.835 . . . . 0.0 110.543 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.45 -38.88 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.301 1.84 . . . . 0.0 110.978 -170.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.76 -47.67 70.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.905 1.282 . . . . 0.0 111.443 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -71.74 -24.46 61.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.104 1.362 . . . . 0.0 114.265 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -73.1 -44.07 60.87 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.809 1.186 . . . . 0.0 112.426 169.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.05 -24.21 35.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.022 1.329 . . . . 0.0 113.617 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.49 22.59 53.54 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.936 1.255 . . . . 0.0 112.643 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -119.14 60.27 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.183 2.193 . . . . 0.0 111.779 -168.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 t -115.02 113.4 24.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.514 1.526 . . . . 0.0 109.962 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -155.66 169.62 23.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 0.0 112.986 -167.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.33 -135.56 51.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.247 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.63 -37.91 95.28 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.612 2.208 . . . . 0.0 113.46 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.69 -34.3 77.55 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.179 -0.951 . . . . 0.0 113.067 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -54.31 -39.22 66.79 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.652 1.581 . . . . 0.0 112.048 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -84.0 -45.17 13.4 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.761 1.224 . . . . 0.0 112.897 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.18 -38.92 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.247 1.419 . . . . 0.0 112.338 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.5 t -92.98 -11.8 32.3 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.903 1.681 . . . . 0.0 112.193 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.09 55.34 9.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.491 2.316 . . . . 0.0 112.8 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.977 1.711 . . . . 0.0 112.325 -179.211 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.18 152.25 86.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.072 0.949 . . . . 0.0 111.798 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -62.98 151.25 85.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.01 2.473 . . . . 0.0 112.957 175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -59.31 -29.35 67.56 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -76.75 -26.3 54.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.67 -46.96 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.278 1.031 . . . . 0.0 109.522 166.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.08 -32.27 70.79 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.648 -0.657 . . . . 0.0 112.421 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -60.57 -36.88 79.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.256 1.022 . . . . 0.0 113.198 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.5 97.34 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.366 -0.834 . . . . 0.0 110.867 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.93 -43.51 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.675 1.59 . . . . 0.0 110.341 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.3 -45.59 80.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.236 1.414 . . . . 0.0 112.15 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -79.78 -28.18 40.34 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -71.96 -37.49 69.94 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.219 0.918 . . . . 0.0 113.081 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.23 -13.83 45.67 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.988 1.315 . . . . 0.0 113.476 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.39 25.77 74.72 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.235 0.922 . . . . 0.0 113.609 -174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -121.0 76.94 1.25 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.643 1.977 . . . . 0.0 109.487 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.8 t -139.43 131.74 28.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.047 1.339 . . . . 0.0 111.205 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.6 170.51 22.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.753 1.621 . . . . 0.0 111.714 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.26 -130.58 44.76 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.281 0.943 . . . . 0.0 113.525 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.31 -39.24 92.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.047 2.498 . . . . 0.0 113.585 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -40.87 98.5 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.289 0.949 . . . . 0.0 111.02 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -65.56 -40.73 93.14 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.964 1.305 . . . . 0.0 111.773 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.2 -38.49 91.25 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.742 0.817 . . . . 0.0 112.444 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.67 -46.21 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.24 1.416 . . . . 0.0 111.831 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.2 t -102.95 -9.02 20.19 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.1 1.36 . . . . 0.0 114.431 -163.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt 55.59 50.54 14.29 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.052 2.141 . . . . 0.0 112.09 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.252 1.188 0 CA-C-N 112.79 -2.005 . . . . 0.0 112.344 178.689 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.101 -0.399 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.25 142.8 92.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.294 1.038 . . . . 0.0 111.6 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.56 158.56 36.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.632 2.888 . . . . 0.0 111.693 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -54.98 -31.3 60.67 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.916 1.451 . . . . 0.0 114.916 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -71.21 -24.72 62.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.6 1.16 . . . . 0.0 114.065 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.9 mt -93.56 -38.84 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.533 1.133 . . . . 0.0 110.337 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -56.13 -28.36 57.63 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.582 -0.699 . . . . 0.0 112.386 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.6 t -56.47 -36.64 69.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.858 0.863 . . . . 0.0 113.282 174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.87 83.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.842 0.829 . . . . 0.0 111.518 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -78.95 -44.39 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.21 1.804 . . . . 0.0 109.228 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.59 -48.51 79.18 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.879 1.271 . . . . 0.0 111.762 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.6 pttt -77.88 -26.23 49.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -69.67 -38.79 77.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.087 0.955 . . . . 0.0 113.429 171.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.81 -26.71 31.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.723 1.209 . . . . 0.0 113.614 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.13 14.23 49.43 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.954 1.264 . . . . 0.0 113.573 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.58 -1.74 57.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.472 2.309 . . . . 0.0 114.141 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.1 t -76.06 97.44 4.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.539 1.063 . . . . 0.0 110.793 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.55 162.38 35.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.708 2.003 . . . . 0.0 110.277 -174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.77 -117.63 4.84 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.49 1.043 . . . . 0.0 113.032 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.94 -39.38 41.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.756 2.304 . . . . 0.0 113.184 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -38.48 90.5 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.244 1.384 . . . . 0.0 111.171 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -67.87 -42.04 81.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.238 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.54 -36.4 83.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.727 0.811 . . . . 0.0 112.528 175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.02 -44.05 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.378 1.471 . . . . 0.0 112.411 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.6 t -110.58 -8.69 14.59 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -164.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.278 0.0 OUTLIER 53.5 66.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.661 2.384 . . . . 0.0 113.576 -171.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.255 1.355 0 C-N-CA 125.125 1.37 . . . . 0.0 112.815 171.77 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.47 145.43 92.9 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.196 0.998 . . . . 0.0 111.595 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.48 153.54 49.93 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.297 2.665 . . . . 0.0 110.886 171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -54.95 -33.11 62.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.77 -18.81 65.0 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.646 1.179 . . . . 0.0 114.163 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.18 -48.83 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.127 1.371 . . . . 0.0 110.145 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.2 tp -57.6 -32.75 67.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.477 1.111 . . . . 0.0 112.519 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.54 -37.8 76.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.94 -28.73 69.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.688 0.795 . . . . 0.0 112.782 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -94.27 -46.97 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 125.881 1.672 . . . . 0.0 108.625 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.94 71.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.36 1.464 . . . . 0.0 112.288 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.43 -22.03 30.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -74.26 -45.11 49.92 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.341 1.056 . . . . 0.0 112.739 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.81 -22.47 37.08 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.443 1.097 . . . . 0.0 113.209 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.12 18.43 39.66 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.616 1.103 . . . . 0.0 113.285 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -88.0 -8.1 56.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.125 2.17 . . . . 0.0 113.534 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -68.63 113.16 5.89 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.724 1.21 . . . . 0.0 111.707 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -139.75 164.42 29.99 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.425 1.89 . . . . 0.0 110.93 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.28 -104.16 0.01 OUTLIER Glycine 0 CA--C 1.541 1.662 0 C-N-CA 126.872 2.177 . . . . 0.0 115.672 170.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.55 -0.92 8.3 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.605 3.537 . . . . 0.0 115.406 -175.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -42.05 4.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.862 1.265 . . . . 0.0 111.084 166.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -58.76 -42.21 88.38 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.335 1.454 . . . . 0.0 111.942 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.94 -32.86 72.76 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.834 1.254 . . . . 0.0 112.918 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.78 -34.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 112.925 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -119.48 -7.05 10.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.448 1.099 . . . . 0.0 113.434 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? 62.45 104.68 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 128.382 2.673 . . . . 0.0 113.232 -171.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.6 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 125.97 1.708 . . . . 0.0 111.607 169.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.6 mt -137.11 151.06 71.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.707 1.603 . . . . 0.0 111.492 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.3 145.8 91.95 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.48 2.787 . . . . 0.0 111.89 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.2 mmt85 -54.54 -39.02 67.27 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.235 1.014 . . . . 0.0 113.553 -175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -66.33 -22.94 66.29 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -94.78 -48.06 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.974 1.31 . . . . 0.0 110.124 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.6 tp -54.72 -33.66 61.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.223 1.409 . . . . 0.0 112.207 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.0 t -60.4 -37.28 80.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.385 1.074 . . . . 0.0 113.066 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.28 71.56 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.515 -0.74 . . . . 0.0 111.418 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.68 -49.0 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.292 1.037 . . . . 0.0 110.192 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.27 75.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.145 1.378 . . . . 0.0 112.783 -172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.51 -25.88 54.68 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -75.63 -37.63 59.57 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.426 1.012 . . . . 0.0 113.271 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.59 -15.85 53.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.084 1.354 . . . . 0.0 113.272 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 25.08 72.34 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.443 1.02 . . . . 0.0 113.869 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -126.2 93.43 3.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.722 1.609 . . . . 0.0 110.335 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -150.21 133.36 16.25 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.763 1.625 . . . . 0.0 110.337 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -157.89 170.25 22.77 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.27 -125.22 27.73 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.9 1.238 . . . . 0.0 113.193 171.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.61 -37.95 34.63 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.155 1.903 . . . . 0.0 112.081 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.82 -37.76 88.59 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 111.863 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -61.32 -40.37 93.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.486 1.114 . . . . 0.0 112.157 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -69.21 -39.78 78.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.676 0.791 . . . . 0.0 112.562 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.3 t -73.89 -39.77 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.503 1.521 . . . . 0.0 112.605 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.8 t -99.7 -11.98 20.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.027 1.731 . . . . 0.0 113.169 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? 55.32 64.9 1.63 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.017 2.127 . . . . 0.0 112.321 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.413 1.485 . . . . 0.0 112.156 -177.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.09 143.8 81.07 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.053 0.941 . . . . 0.0 111.72 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.36 156.41 45.9 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.247 2.632 . . . . 0.0 110.88 172.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -54.19 -38.63 65.83 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -170.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.23 -41.2 90.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.206 1.002 . . . . 0.0 112.433 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.32 -45.91 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.901 0.88 . . . . 0.0 109.898 175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.56 -34.29 70.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.41 1.084 . . . . 0.0 112.22 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.09 -37.29 76.76 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.632 1.173 . . . . 0.0 113.034 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -34.34 69.31 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.51 -0.744 . . . . 0.0 111.607 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 mm -68.77 -46.82 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.272 1.029 . . . . 0.0 110.401 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.07 70.98 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.938 1.295 . . . . 0.0 112.646 -173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.49 -24.89 59.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.059 . . . . 0.0 113.84 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -73.66 -40.28 63.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.225 1.01 . . . . 0.0 112.663 173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -80.54 -19.5 45.6 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.286 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.78 25.97 68.33 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.405 1.002 . . . . 0.0 113.556 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -125.79 92.46 3.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.989 1.716 . . . . 0.0 110.184 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.6 t -147.3 131.59 17.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.559 1.544 . . . . 0.0 110.591 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 171.65 20.08 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.5 -124.77 34.46 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.725 1.155 . . . . 0.0 112.884 171.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.17 -37.0 19.68 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.021 1.814 . . . . 0.0 112.162 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.6 tp -64.21 -36.84 85.38 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.96 -1.087 . . . . 0.0 112.175 -176.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -54.64 -44.6 73.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.079 1.752 . . . . 0.0 111.975 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tt -72.21 -44.9 62.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.584 1.154 . . . . 0.0 112.179 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.79 -44.95 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.105 1.362 . . . . 0.0 112.15 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -95.87 -11.61 26.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.708 1.603 . . . . 0.0 113.858 -170.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp 52.97 58.81 4.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.594 1.958 . . . . 0.0 111.893 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.2 m . . . . . 0 C--O 1.252 1.236 0 CA-C-N 112.803 -1.999 . . . . 0.0 112.942 -179.431 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 121.592 0.551 . . . . 0.0 112.946 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.7 mt -77.2 153.88 82.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 129.241 3.016 . . . . 0.0 112.638 -1.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.46 159.16 32.59 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.768 2.979 . . . . 0.0 112.125 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -53.41 -36.87 61.96 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.054 1.342 . . . . 0.0 113.852 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -68.42 -20.41 64.66 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -96.02 -45.21 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.44 1.096 . . . . 0.0 110.352 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -55.4 -32.61 62.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 112.492 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -59.96 -37.76 80.51 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.176 0.99 . . . . 0.0 112.924 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 -36.36 68.4 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.518 -0.739 . . . . 0.0 111.589 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.7 mm -66.35 -47.36 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.12 0.968 . . . . 0.0 110.424 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -50.99 71.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 112.551 -173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -74.84 -22.79 58.49 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -74.84 -40.05 61.26 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.012 0.925 . . . . 0.0 112.474 171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.4 -20.19 44.55 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.243 1.417 . . . . 0.0 113.671 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.84 27.14 67.47 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.139 0.875 . . . . 0.0 113.172 -170.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.25 81.47 1.97 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.743 2.017 . . . . 0.0 109.661 -172.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.59 134.72 29.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 110.455 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.78 166.58 32.37 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.91 -123.35 13.55 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.288 1.423 . . . . 0.0 113.568 171.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.78 -37.78 43.43 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.298 1.999 . . . . 0.0 112.195 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp -65.7 -36.88 84.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.828 1.195 . . . . 0.0 111.855 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -63.62 -41.61 98.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.321 1.049 . . . . 0.0 111.907 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.5 tp -65.51 -38.82 90.8 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.282 0.633 . . . . 0.0 112.626 174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.59 -46.05 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.356 1.462 . . . . 0.0 111.991 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.43 -10.12 28.29 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.531 1.533 . . . . 0.0 114.058 -169.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 56.41 50.09 13.76 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.092 2.157 . . . . 0.0 112.192 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.253 1.255 0 CA-C-N 112.811 -1.995 . . . . 0.0 112.979 179.678 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.62 145.48 84.73 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.093 0.957 . . . . 0.0 111.944 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.112 2.541 . . . . 0.0 110.438 167.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -54.67 -32.75 59.76 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.82 -25.62 62.93 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -94.51 -39.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.533 1.133 . . . . 0.0 110.481 173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.03 -30.5 61.99 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.115 0.966 . . . . 0.0 111.176 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.5 t -58.13 -31.46 67.21 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.27 -27.85 66.69 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.123 -0.986 . . . . 0.0 112.024 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -78.23 -47.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 109.657 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.78 75.64 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.496 1.518 . . . . 0.0 112.613 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -81.62 -30.74 32.75 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 0.0 113.239 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -69.45 -40.12 77.36 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.416 1.086 . . . . 0.0 112.444 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -85.98 -12.42 50.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.467 1.507 . . . . 0.0 113.606 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.62 22.7 78.63 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.328 0.966 . . . . 0.0 113.849 -174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -94.97 -5.05 45.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.612 1.965 . . . . 0.0 113.692 -174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.79 110.76 3.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.192 -0.942 . . . . 0.0 112.003 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -144.07 165.77 26.87 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.579 1.952 . . . . 0.0 110.642 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.59 -128.41 42.29 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.903 -0.943 . . . . 0.0 112.99 171.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.82 -39.28 92.1 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.243 2.628 . . . . 0.0 113.825 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -39.24 92.62 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.517 1.053 . . . . 0.0 111.534 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -70.99 -37.06 72.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.035 1.334 . . . . 0.0 111.711 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.77 -41.47 97.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.052 0.941 . . . . 0.0 111.737 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.93 -43.55 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.593 1.557 . . . . 0.0 112.181 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.4 t -115.7 7.21 14.64 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.586 1.154 . . . . 0.0 113.842 -163.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.283 0.4 OUTLIER 47.11 38.72 6.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.107 2.563 . . . . 0.0 113.638 175.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.251 1.179 0 C-N-CA 126.747 2.019 . . . . 0.0 112.963 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 150.61 73.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.652 1.581 . . . . 0.0 111.269 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.53 145.05 95.43 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.55 2.167 . . . . 0.0 110.527 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -65.0 -27.54 68.9 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -167.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.65 -41.46 97.55 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.596 1.158 . . . . 0.0 112.367 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.44 -46.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.487 1.115 . . . . 0.0 109.819 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.71 -31.78 71.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.828 0.851 . . . . 0.0 112.248 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.33 -29.84 70.12 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.74 -31.75 71.03 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.201 -0.937 . . . . 0.0 111.281 176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.0 -48.2 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.452 1.101 . . . . 0.0 109.95 169.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.53 84.56 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.453 1.101 . . . . 0.0 112.617 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.18 -27.23 47.93 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.915 0.886 . . . . 0.0 113.361 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -72.82 -41.45 64.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.447 1.099 . . . . 0.0 112.27 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -85.09 -19.91 31.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.78 1.232 . . . . 0.0 113.737 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 25.94 42.74 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.344 0.973 . . . . 0.0 113.024 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -100.14 -3.64 31.34 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.756 2.422 . . . . 0.0 114.734 -172.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 t -74.57 113.13 11.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.847 0.749 . . . . 0.0 111.6 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -155.38 167.22 31.09 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.597 1.959 . . . . 0.0 110.457 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.47 -127.73 42.81 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.664 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.53 -42.28 67.16 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.181 2.587 . . . . 0.0 113.659 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -39.43 94.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.577 1.081 . . . . 0.0 111.405 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.95 -39.02 87.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.6 tp -68.05 -37.37 81.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.933 0.893 . . . . 0.0 112.57 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -72.66 -40.54 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.55 1.54 . . . . 0.0 112.341 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t -110.29 -11.94 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -168.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.261 6.1 tmtt? 56.33 60.76 2.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.754 2.021 . . . . 0.0 112.916 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.584 1.553 . . . . 0.0 112.741 177.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.02 152.17 92.81 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.267 1.027 . . . . 0.0 111.741 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -74.6 160.01 41.88 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.808 3.005 . . . . 0.0 111.878 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -53.63 -35.68 61.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.922 1.289 . . . . 0.0 113.955 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.71 -23.21 66.71 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.9 mt -95.79 -42.62 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.077 1.351 . . . . 0.0 110.755 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.43 -32.47 66.92 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.51 -0.743 . . . . 0.0 112.389 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -63.01 -34.48 77.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.999 0.919 . . . . 0.0 113.287 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.88 94.15 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.315 -0.865 . . . . 0.0 110.766 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.2 mt -76.03 -45.04 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 110.412 -171.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.63 80.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.111 1.364 . . . . 0.0 112.315 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -79.16 -30.19 43.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.2 -36.15 63.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.425 1.011 . . . . 0.0 113.383 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.33 -13.79 54.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.96 1.304 . . . . 0.0 113.177 173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.71 24.43 74.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.591 1.091 . . . . 0.0 114.196 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -126.65 95.46 4.35 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.612 1.565 . . . . 0.0 110.437 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.58 133.7 18.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.683 1.593 . . . . 0.0 110.375 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -155.68 168.61 26.63 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.967 1.307 . . . . 0.0 112.536 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.62 -121.03 8.42 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.193 1.378 . . . . 0.0 113.678 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.86 -38.57 38.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.432 2.088 . . . . 0.0 112.332 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -40.67 98.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.814 1.188 . . . . 0.0 110.751 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 tttp -65.26 -41.93 93.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 111.871 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.82 -38.75 92.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.675 0.79 . . . . 0.0 112.479 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.7 t -73.14 -44.62 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.424 1.49 . . . . 0.0 112.057 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.1 t -103.7 -8.97 19.49 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.351 1.46 . . . . 0.0 114.284 -165.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt 55.59 52.1 11.6 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.02 2.128 . . . . 0.0 112.018 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.7 m . . . . . 0 C--O 1.252 1.215 0 CA-C-N 112.809 -1.996 . . . . 0.0 112.288 178.594 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.53 148.06 87.65 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.0 0.92 . . . . 0.0 112.216 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.29 160.91 38.67 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.62 2.88 . . . . 0.0 111.526 172.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -54.61 -34.6 62.3 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.857 1.263 . . . . 0.0 113.288 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -52.58 -40.36 62.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.293 2.237 . . . . 0.0 113.215 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.8 mt -101.3 -31.79 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.588 1.155 . . . . 0.0 111.24 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.91 -31.2 62.66 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.129 -0.982 . . . . 0.0 111.67 166.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.81 -30.94 68.58 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -39.91 82.78 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.962 -1.086 . . . . 0.0 110.612 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -61.29 -49.69 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.072 0.949 . . . . 0.0 110.316 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.79 81.45 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.183 0.993 . . . . 0.0 112.237 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -72.37 -32.58 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.597 0.759 . . . . 0.0 112.798 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -70.71 -37.42 73.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.736 1.215 . . . . 0.0 113.313 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.53 -22.76 32.32 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.996 1.318 . . . . 0.0 113.897 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.24 21.55 44.78 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.812 1.196 . . . . 0.0 113.343 -174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.07 7.09 31.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.611 2.365 . . . . 0.0 114.204 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 t -77.45 87.23 3.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.658 1.117 . . . . 0.0 110.492 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -139.5 160.18 40.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 110.032 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.16 -118.87 7.99 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 118.913 -0.937 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.39 -39.43 37.11 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.664 2.243 . . . . 0.0 113.048 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -36.66 84.13 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.07 1.304 . . . . 0.0 111.546 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -66.5 -40.21 89.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.107 1.363 . . . . 0.0 111.703 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.33 -37.37 83.2 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.45 0.7 . . . . 0.0 112.247 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.07 -47.68 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.383 1.473 . . . . 0.0 111.923 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -104.93 -8.62 18.5 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 56.66 51.34 11.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 127.086 2.154 . . . . 0.0 112.31 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.5 m . . . . . 0 C--O 1.251 1.166 0 CA-C-N 112.733 -2.03 . . . . 0.0 112.584 177.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.441 0.467 . . . . 0.0 112.91 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.0 mt -133.12 151.1 77.19 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 130.699 3.6 . . . . 0.0 110.841 1.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -70.53 152.43 65.3 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.932 2.422 . . . . 0.0 110.456 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -57.35 -33.14 67.46 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -170.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -68.2 -22.59 64.8 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.0 mt -99.16 -41.11 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.739 1.216 . . . . 0.0 110.403 173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.39 -26.43 63.19 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.365 1.066 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 14.3 t -63.55 -26.44 68.7 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.92 88.82 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.637 -1.289 . . . . 0.0 110.947 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.61 -44.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.841 1.256 . . . . 0.0 110.227 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.9 85.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -172.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -74.58 -42.95 57.82 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 119.812 1.187 . . . . 0.0 111.868 169.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.788 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -91.61 -9.9 42.38 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.887 1.675 . . . . 0.0 114.109 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.1 28.47 72.84 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.101 0.858 . . . . 0.0 113.514 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -102.57 -10.17 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.994 2.118 . . . . 0.0 114.314 -168.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 112.03 3.79 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.171 -0.955 . . . . 0.0 112.374 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.89 164.59 29.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.757 2.023 . . . . 0.0 110.67 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 36.09 -107.21 0.04 OUTLIER Glycine 0 CA--C 1.54 1.623 0 C-N-CA 126.422 1.963 . . . . 0.0 115.445 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.38 -4.58 14.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.357 3.372 . . . . 0.0 115.309 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -41.62 5.86 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.367 1.067 . . . . 0.0 111.155 167.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.313 1.045 . . . . 0.0 111.672 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.1 tp -67.76 -26.85 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.538 1.135 . . . . 0.0 113.189 175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -89.5 -34.26 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.579 1.551 . . . . 0.0 112.407 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.2 t -113.01 -10.41 13.49 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.976 1.31 . . . . 0.0 113.565 -173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER 57.31 58.85 3.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.863 2.065 . . . . 0.0 112.687 -175.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.117 1.367 . . . . 0.0 112.22 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.7 mt -136.34 151.66 73.6 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.682 1.593 . . . . 0.0 111.456 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.14 146.47 81.13 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.581 2.854 . . . . 0.0 111.969 168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.0 mmt85 -53.56 -47.48 70.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.543 0.737 . . . . 0.0 112.942 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -63.56 -23.64 67.47 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -87.51 -48.1 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.461 1.104 . . . . 0.0 110.242 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.83 -36.13 69.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.576 1.151 . . . . 0.0 111.191 176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.0 m -70.88 -20.49 62.51 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.7 -14.06 60.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.308 0.958 . . . . 0.0 112.301 170.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.27 -51.69 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.775 1.23 . . . . 0.0 109.245 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.1 90.15 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.748 0.819 . . . . 0.0 112.956 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.63 -22.82 46.36 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.41 -38.37 65.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -86.97 -19.04 29.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.33 1.452 . . . . 0.0 114.154 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.9 21.92 73.02 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.34 0.972 . . . . 0.0 113.78 -169.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -99.16 44.28 1.03 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.177 2.191 . . . . 0.0 112.393 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.0 t -123.47 131.66 53.7 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.328 1.451 . . . . 0.0 112.12 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 167.17 26.09 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 126.616 1.966 . . . . 0.0 111.403 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 33.33 -106.0 0.02 OUTLIER Glycine 0 CA--C 1.54 1.655 0 C-N-CA 127.231 2.348 . . . . 0.0 115.939 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.48 -1.0 8.35 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.338 3.359 . . . . 0.0 115.047 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.2 -41.72 5.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.345 1.458 . . . . 0.0 111.756 167.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -53.77 -40.68 66.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.171 1.788 . . . . 0.0 111.247 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.1 tp -77.59 -11.65 59.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.192 1.797 . . . . 0.0 114.781 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.22 -33.78 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.469 1.031 . . . . 0.0 111.811 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.46 -5.66 12.86 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.814 1.246 . . . . 0.0 113.543 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.253 32.7 ttpt 41.36 107.5 0.0 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 129.499 3.12 . . . . 0.0 115.198 -161.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.371 1.468 . . . . 0.0 113.097 -175.831 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 CA-C-O 121.639 0.577 . . . . 0.0 112.951 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -80.87 147.99 63.56 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 129.224 3.01 . . . . 0.0 111.966 -1.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.36 156.36 41.38 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.171 2.581 . . . . 0.0 111.14 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -53.95 -35.54 61.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.723 1.209 . . . . 0.0 114.115 -174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -60.95 -41.44 96.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.731 1.212 . . . . 0.0 112.826 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.33 -45.54 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.696 1.199 . . . . 0.0 109.993 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.46 -29.23 70.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 112.817 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -57.95 -37.97 75.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.033 0.833 . . . . 0.0 112.837 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.62 -14.11 62.65 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.3 mt -107.91 -42.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.795 1.638 . . . . 0.0 109.136 -173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.41 64.71 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.718 1.607 . . . . 0.0 112.584 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -87.2 -22.69 25.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -63.99 -39.76 94.85 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.501 1.046 . . . . 0.0 112.914 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.7 -14.7 34.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 125.193 1.397 . . . . 0.0 113.844 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 27.62 66.06 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.107 0.86 . . . . 0.0 113.734 -175.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -119.09 71.41 0.86 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.264 2.226 . . . . 0.0 109.66 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -143.09 134.78 26.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.632 1.573 . . . . 0.0 111.008 -172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -157.75 170.21 22.88 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.19 1.396 . . . . 0.0 112.444 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.07 -121.2 9.32 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.185 1.374 . . . . 0.0 113.527 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.95 -38.85 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.446 2.097 . . . . 0.0 112.39 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.44 -39.9 95.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.806 1.185 . . . . 0.0 110.921 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -62.86 -43.5 98.64 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.651 1.18 . . . . 0.0 111.585 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -63.67 -45.46 90.03 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.286 1.034 . . . . 0.0 111.892 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.89 -39.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.709 1.604 . . . . 0.0 112.713 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -107.58 -13.12 15.13 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.999 1.32 . . . . 0.0 113.532 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 54.14 59.14 4.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.704 2.002 . . . . 0.0 112.471 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.798 1.639 . . . . 0.0 112.604 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 CA-C-O 121.633 0.574 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.56 161.18 77.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 129.136 2.974 . . . . 0.0 112.415 -1.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -59.3 148.06 88.07 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.323 2.682 . . . . 0.0 112.252 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -34.34 59.75 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -57.27 -43.71 83.31 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.619 1.568 . . . . 0.0 112.018 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.3 mt -93.03 -42.74 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.683 1.593 . . . . 0.0 110.368 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.9 tp -57.42 -34.19 68.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.358 1.063 . . . . 0.0 111.557 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.32 -36.32 83.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.49 -35.64 79.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.447 1.021 . . . . 0.0 111.148 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.23 -44.23 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.259 1.423 . . . . 0.0 110.782 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.68 88.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.239 1.015 . . . . 0.0 113.532 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -61.58 -49.34 77.01 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 110.699 169.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 tptt -59.24 -43.12 92.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.036 1.735 . . . . 0.0 113.085 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -90.71 -11.35 39.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.327 1.451 . . . . 0.0 114.051 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.53 25.16 75.79 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.935 0.779 . . . . 0.0 113.447 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -98.08 0.3 45.87 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.469 1.908 . . . . 0.0 113.607 -171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.68 113.13 6.66 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 111.178 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -145.15 163.02 35.64 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.245 1.418 . . . . 0.0 112.296 -170.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.14 -120.69 8.6 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.108 1.337 . . . . 0.0 113.23 172.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.21 -40.07 34.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.316 2.011 . . . . 0.0 112.229 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.76 -34.84 79.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.068 1.304 . . . . 0.0 112.175 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -65.49 -39.96 92.52 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.773 1.229 . . . . 0.0 112.257 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.36 -43.61 81.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.584 0.754 . . . . 0.0 111.713 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.4 t -70.33 -42.58 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.236 1.415 . . . . 0.0 111.85 -176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.9 t -109.12 10.25 26.02 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.716 1.207 . . . . 0.0 114.167 -172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 50.26 55.32 9.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.773 2.429 . . . . 0.0 112.851 171.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m . . . . . 0 C--O 1.253 1.253 0 CA-C-N 113.205 -1.816 . . . . 0.0 113.421 179.453 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.33 146.85 84.71 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.067 0.947 . . . . 0.0 111.625 178.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 150.53 85.22 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.034 2.49 . . . . 0.0 112.159 172.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -55.07 -36.77 65.96 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -60.58 -48.19 82.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.734 1.214 . . . . 0.0 112.367 177.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.25 -49.39 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.544 1.138 . . . . 0.0 109.798 176.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.4 tp -61.67 -30.37 70.68 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 112.589 -175.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.7 t -62.49 -39.02 92.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.218 1.007 . . . . 0.0 112.734 172.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.82 77.15 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.309 -0.869 . . . . 0.0 110.482 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.8 mm -58.61 -47.01 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.295 1.038 . . . . 0.0 111.008 175.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.84 91.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.537 1.135 . . . . 0.0 112.484 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -82.37 -26.2 33.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -71.65 -38.3 70.73 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.044 0.938 . . . . 0.0 112.764 171.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.64 -15.66 39.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.459 1.104 . . . . 0.0 113.75 176.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.19 27.86 71.12 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.006 0.812 . . . . 0.0 113.458 -174.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -107.46 23.21 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.644 1.978 . . . . 0.0 112.974 -172.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.61 116.89 29.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.792 1.237 . . . . 0.0 111.706 -175.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -158.44 172.58 18.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.79 1.636 . . . . 0.0 112.015 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.54 -128.44 47.47 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.04 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.21 -31.46 44.52 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.207 1.938 . . . . 0.0 112.685 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -38.39 90.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.616 1.098 . . . . 0.0 111.389 -177.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -59.84 -37.37 79.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.845 1.258 . . . . 0.0 112.523 174.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -71.42 -43.23 67.16 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 173.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.17 -36.55 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.406 1.482 . . . . 0.0 112.804 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -116.09 -7.16 11.91 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.541 1.537 . . . . 0.0 113.738 -163.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? 53.09 65.31 1.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.608 2.363 . . . . 0.0 112.593 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.522 1.529 . . . . 0.0 112.485 -174.809 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.36 144.04 86.29 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.201 1.0 . . . . 0.0 111.788 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -68.61 146.86 68.75 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.837 2.358 . . . . 0.0 109.902 170.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -65.86 -25.3 67.13 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -166.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.81 -21.04 66.46 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.434 1.093 . . . . 0.0 113.935 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -98.96 -49.13 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.201 1.4 . . . . 0.0 110.248 171.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.04 -29.64 67.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.62 0.768 . . . . 0.0 112.658 -175.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -62.02 -35.52 78.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 0.0 113.025 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.65 87.26 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.012 -1.055 . . . . 0.0 110.746 176.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.07 -45.0 99.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.449 1.099 . . . . 0.0 110.476 174.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -55.33 -48.52 74.06 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.559 1.543 . . . . 0.0 112.289 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.75 -44.31 70.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.642 1.577 . . . . 0.0 113.209 176.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.6 -36.09 78.23 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -90.66 -12.47 36.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.607 1.163 . . . . 0.0 113.585 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.09 33.34 83.09 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 118.874 0.761 . . . . 0.0 112.137 -171.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -97.87 -12.54 22.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.534 1.933 . . . . 0.0 111.74 -172.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 15.9 p -59.66 116.44 4.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.317 1.847 . . . . 0.0 111.564 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 155.37 43.96 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.85 1.66 . . . . 0.0 110.88 -177.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 40.63 -114.76 0.57 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.752 1.644 . . . . 0.0 113.856 171.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -63.66 -42.1 22.11 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.615 2.21 . . . . 0.0 112.729 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -66.94 -37.36 84.16 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.507 1.503 . . . . 0.0 112.262 -178.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -63.9 -43.83 94.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.735 0.814 . . . . 0.0 111.032 171.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.22 -37.61 87.92 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 176.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.92 -47.31 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.152 1.381 . . . . 0.0 111.261 174.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -80.03 -17.93 51.5 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -175.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm 54.1 47.97 22.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.862 2.065 . . . . 0.0 111.61 -171.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.253 1.245 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.528 -175.166 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.59 147.86 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.415 2.686 . . . . 0.0 115.253 -172.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.07 154.69 47.42 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.263 2.642 . . . . 0.0 110.901 172.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -50.65 -39.28 50.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.884 1.273 . . . . 0.0 113.815 -175.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.71 -18.08 65.19 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -179.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.73 -49.0 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.116 1.366 . . . . 0.0 110.198 172.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.67 -33.34 66.29 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.419 1.487 . . . . 0.0 112.015 -177.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.7 t -58.54 -42.59 88.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.956 0.902 . . . . 0.0 112.544 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.59 80.6 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.321 -0.862 . . . . 0.0 111.314 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.81 -48.31 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.922 0.889 . . . . 0.0 110.263 173.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.97 -45.18 91.17 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.267 1.027 . . . . 0.0 113.715 -170.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -88.58 -14.93 36.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -74.63 -37.85 62.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.452 0.701 . . . . 0.0 112.803 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -85.13 -18.06 35.36 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.101 1.36 . . . . 0.0 113.728 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.73 22.98 65.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.526 1.06 . . . . 0.0 114.402 -178.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -101.53 13.94 33.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.147 1.779 . . . . 0.0 113.581 -177.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.04 104.0 15.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.687 1.195 . . . . 0.0 111.603 -176.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -146.36 169.08 19.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.432 1.493 . . . . 0.0 112.603 -173.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 -128.49 47.59 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.835 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -65.78 -32.48 46.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 CA-C-N 119.819 1.81 . . . . 0.0 112.436 176.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.8 tp -65.36 -34.99 79.62 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.757 1.162 . . . . 0.0 112.408 -176.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -58.95 -34.56 71.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.691 1.196 . . . . 0.0 112.509 172.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 tp -77.73 -43.88 29.53 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.732 0.813 . . . . 0.0 112.558 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.8 -38.97 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.348 1.459 . . . . 0.0 112.633 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -102.22 -8.88 20.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.009 1.724 . . . . 0.0 112.904 -173.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.03 79.72 0.08 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 128.113 2.565 . . . . 0.0 112.552 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.154 0 C-N-CA 124.556 1.142 . . . . 0.0 110.603 -179.503 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.043 -0.423 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.02 150.18 87.86 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.098 0.959 . . . . 0.0 112.277 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.57 159.26 35.75 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.811 3.007 . . . . 0.0 112.121 175.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -54.94 -34.22 63.02 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.285 . . . . 0.0 113.718 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -21.97 66.05 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.81 -45.05 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 110.406 172.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.7 mt -57.24 -30.09 64.33 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.7 t -57.94 -41.03 81.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.483 1.113 . . . . 0.0 112.407 174.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.67 79.5 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.229 -0.919 . . . . 0.0 111.102 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.57 -48.68 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.503 1.121 . . . . 0.0 110.479 177.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.5 95.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.77 1.228 . . . . 0.0 112.344 -178.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HE2' ' SG ' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -70.61 -38.68 74.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.323 1.049 . . . . 0.0 112.661 179.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.2 -39.57 60.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.91 0.884 . . . . 0.0 113.287 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -82.84 -26.63 31.49 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.11 75.67 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.638 1.113 . . . . 0.0 113.267 -174.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -70.61 -7.3 43.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.44 2.296 . . . . 0.0 113.911 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.0 t -70.49 115.44 9.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.926 1.29 . . . . 0.0 112.631 -174.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -148.12 166.6 27.34 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.903 2.081 . . . . 0.0 110.946 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.24 -131.47 48.58 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.09 0.852 . . . . 0.0 113.484 171.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.05 -38.41 94.82 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.965 2.444 . . . . 0.0 113.553 176.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -39.27 94.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.276 0.944 . . . . 0.0 111.194 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -65.2 -41.19 94.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.042 1.337 . . . . 0.0 111.843 175.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.27 -39.26 92.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.635 0.774 . . . . 0.0 112.653 174.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.27 -45.11 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.407 1.483 . . . . 0.0 112.162 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.5 t -99.94 -9.18 23.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.387 1.475 . . . . 0.0 113.935 -167.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 54.61 62.34 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.947 2.099 . . . . 0.0 111.535 -178.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' SG ' ' HE2' ' A' ' 12' ' ' LYS . 65.4 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.784 -2.007 . . . . 0.0 112.336 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.31 147.64 85.48 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.068 0.947 . . . . 0.0 112.106 178.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.46 168.51 9.97 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.443 2.762 . . . . 0.0 111.307 172.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.43 -35.58 60.6 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.652 1.181 . . . . 0.0 112.944 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -56.68 -35.65 68.7 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.243 1.817 . . . . 0.0 113.964 177.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -91.42 -45.57 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.868 0.867 . . . . 0.0 110.589 175.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.62 -25.92 66.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.027 0.931 . . . . 0.0 112.727 -175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.8 t -61.08 -36.1 78.73 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.457 1.103 . . . . 0.0 113.184 174.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.89 89.59 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.074 -1.016 . . . . 0.0 110.804 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.98 -40.71 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.721 1.608 . . . . 0.0 110.328 -171.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.44 -36.54 71.53 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.046 1.339 . . . . 0.0 112.685 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.11 -30.79 19.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.681 1.193 . . . . 0.0 113.551 178.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -68.77 -37.96 79.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 172.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -89.55 -14.49 35.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.031 1.332 . . . . 0.0 113.546 176.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.53 21.62 78.71 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.292 0.948 . . . . 0.0 114.148 -176.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -89.09 -7.37 55.95 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.094 1.758 . . . . 0.0 113.478 -175.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.7 t -66.32 120.39 13.21 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.075 1.35 . . . . 0.0 113.358 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -146.04 165.73 28.19 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.017 1.727 . . . . 0.0 112.15 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 50.87 -121.15 10.28 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.334 1.445 . . . . 0.0 113.748 169.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.66 -36.28 53.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.48 2.12 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -39.45 93.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.668 1.122 . . . . 0.0 110.757 178.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -65.23 -42.04 93.78 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.721 1.208 . . . . 0.0 111.754 176.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.66 -42.35 96.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.964 0.906 . . . . 0.0 112.147 173.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -71.78 -43.76 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.319 1.447 . . . . 0.0 112.544 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -105.32 -5.98 20.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.539 1.536 . . . . 0.0 114.131 -164.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 56.66 47.33 18.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.418 2.287 . . . . 0.0 112.553 175.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m . . . . . 0 C--O 1.253 1.261 0 CA-C-N 112.528 -2.124 . . . . 0.0 113.267 -178.2 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.6 mt -73.32 147.45 87.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.113 0.965 . . . . 0.0 112.117 178.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.22 154.31 56.71 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.436 2.757 . . . . 0.0 111.011 173.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -55.29 -34.67 64.32 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.576 1.15 . . . . 0.0 113.799 -173.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.29 -21.9 66.28 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.762 1.225 . . . . 0.0 114.155 178.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.3 mt -99.02 -46.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.182 1.393 . . . . 0.0 110.149 172.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.79 -26.69 68.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.18 0.992 . . . . 0.0 112.825 -175.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.2 t -62.06 -39.69 93.23 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.395 1.078 . . . . 0.0 112.624 170.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.54 -42.92 73.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.049 -1.032 . . . . 0.0 110.684 176.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.12 -47.88 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.107 0.963 . . . . 0.0 111.062 175.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.53 74.74 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.436 1.095 . . . . 0.0 112.106 -178.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -74.39 -37.04 63.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.737 1.215 . . . . 0.0 113.375 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -70.23 -36.69 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.404 1.082 . . . . 0.0 113.234 178.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -83.6 -12.58 55.88 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.09 1.356 . . . . 0.0 113.043 173.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.63 23.22 73.44 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.634 1.111 . . . . 0.0 114.358 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -128.69 102.29 6.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.263 1.425 . . . . 0.0 110.469 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 t -148.65 115.17 5.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.034 1.334 . . . . 0.0 109.924 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -145.36 166.48 25.45 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.608 1.563 . . . . 0.0 111.469 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.14 -130.93 48.06 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.211 0.91 . . . . 0.0 113.038 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.63 -38.38 94.27 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.066 2.511 . . . . 0.0 113.601 177.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -41.51 97.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.47 1.032 . . . . 0.0 111.271 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.29 -37.21 84.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.111 1.364 . . . . 0.0 112.223 174.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -66.49 -37.82 85.92 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.803 0.841 . . . . 0.0 112.226 174.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.4 t -72.83 -44.52 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.468 1.507 . . . . 0.0 111.837 176.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 t -103.21 0.31 31.49 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.789 1.635 . . . . 0.0 113.971 -165.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.351 0.0 OUTLIER 51.97 25.12 2.93 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 129.145 2.978 . . . . 0.0 115.945 -178.398 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 127.4 2.28 . . . . 0.0 114.586 -174.228 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.511 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.5 mt 54.85 142.27 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.108 1 C-N-CA 133.824 4.85 . . . . 0.0 116.312 12.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.72 156.28 48.89 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.981 2.454 . . . . 0.0 110.475 164.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.48 -35.62 65.72 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.255 1.022 . . . . 0.0 113.441 -174.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.31 -38.6 77.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.33 1.852 . . . . 0.0 113.535 176.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.1 mt -95.24 -39.28 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.557 1.143 . . . . 0.0 110.743 -177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.2 tp -54.73 -33.38 61.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 172.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.0 t -60.82 -33.89 73.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.58 -26.6 62.68 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.043 0.838 . . . . 0.0 112.31 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.2 mm -74.19 -48.67 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.049 0.94 . . . . 0.0 109.275 166.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.35 73.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.153 0.981 . . . . 0.0 112.892 -171.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -75.48 -20.55 58.72 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 178.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -72.47 -36.4 68.46 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.134 0.974 . . . . 0.0 112.783 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -88.79 -15.64 34.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.634 1.574 . . . . 0.0 114.452 177.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.16 19.36 69.76 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.566 1.079 . . . . 0.0 114.234 -171.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -100.86 4.99 43.23 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.936 2.095 . . . . 0.0 113.939 -175.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.85 98.56 2.47 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.769 -1.207 . . . . 0.0 110.075 176.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.89 162.38 37.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.591 1.556 . . . . 0.0 111.279 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.43 -131.98 49.2 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.133 179.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.77 -38.72 95.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.925 2.417 . . . . 0.0 113.748 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.75 -36.13 83.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.819 1.19 . . . . 0.0 112.776 -175.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -63.37 -40.22 96.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.685 1.194 . . . . 0.0 111.596 174.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -72.53 -37.9 68.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.569 1.147 . . . . 0.0 112.501 176.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -69.32 -46.28 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.728 1.611 . . . . 0.0 111.393 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -94.82 -11.4 28.94 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -175.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt 56.16 63.56 1.97 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.471 1.908 . . . . 0.0 111.954 -172.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.0 m . . . . . 0 C--O 1.252 1.199 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.77 177.542 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -74.44 150.03 86.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.077 0.951 . . . . 0.0 112.055 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.78 157.1 39.62 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.695 2.93 . . . . 0.0 112.132 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -55.95 -35.05 66.24 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -170.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.55 -22.31 61.02 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 176.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.52 -38.91 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 110.259 172.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt -56.72 -28.51 61.12 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.471 -0.768 . . . . 0.0 112.263 169.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.57 -30.68 71.76 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.09 -33.09 73.87 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.074 -1.016 . . . . 0.0 111.355 176.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.25 -48.07 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.75 85.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.883 1.273 . . . . 0.0 112.7 -175.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -79.02 -29.04 43.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.808 0.843 . . . . 0.0 113.003 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -72.17 -38.7 69.07 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.45 1.1 . . . . 0.0 112.454 174.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -83.09 -16.35 47.25 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.295 1.438 . . . . 0.0 114.088 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.79 22.33 79.13 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.947 0.784 . . . . 0.0 113.587 -170.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -92.42 -8.07 45.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.158 2.183 . . . . 0.0 113.516 -174.445 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -70.1 107.09 3.5 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.255 0.934 . . . . 0.0 112.034 -175.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.54 165.6 27.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.456 1.902 . . . . 0.0 110.747 -178.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.52 -120.48 10.13 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.611 1.101 . . . . 0.0 112.999 174.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.77 -40.05 48.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.653 2.236 . . . . 0.0 112.884 -177.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -38.48 91.09 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.016 1.28 . . . . 0.0 111.346 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -69.41 -38.49 77.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.237 1.415 . . . . 0.0 111.76 177.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.91 -39.02 83.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.685 1.194 . . . . 0.0 112.778 173.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.22 -45.37 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.232 1.413 . . . . 0.0 111.567 176.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.9 -7.9 14.93 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -164.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 55.6 51.16 13.06 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.828 2.051 . . . . 0.0 112.254 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.0 m . . . . . 0 C--O 1.252 1.212 0 CA-C-N 113.079 -1.873 . . . . 0.0 112.221 178.144 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.83 151.4 75.61 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.861 1.664 . . . . 0.0 111.338 178.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.22 158.06 41.54 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.657 2.905 . . . . 0.0 111.926 175.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -57.54 -32.63 67.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.666 1.186 . . . . 0.0 113.589 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -67.81 -21.01 65.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 76.3 mt -96.76 -43.05 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.803 1.241 . . . . 0.0 110.637 173.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -56.7 -31.65 64.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.807 0.73 . . . . 0.0 112.426 175.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 t -62.64 -30.58 71.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.29 -42.56 86.89 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.409 1.004 . . . . 0.0 111.195 176.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.01 -43.89 28.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 126.318 1.847 . . . . 0.0 109.02 -177.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.55 87.49 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.031 0.933 . . . . 0.0 112.667 177.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -38.9 78.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.858 0.863 . . . . 0.0 112.299 176.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -73.58 -39.07 64.93 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.234 1.014 . . . . 0.0 113.406 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -88.27 -17.46 30.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.627 1.171 . . . . 0.0 113.602 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.24 22.99 42.25 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 125.098 1.332 . . . . 0.0 113.175 178.004 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -101.27 3.8 41.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.108 2.163 . . . . 0.0 114.568 -169.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.53 111.8 8.02 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.226 0.921 . . . . 0.0 111.006 -178.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -145.77 163.62 34.43 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.19 1.396 . . . . 0.0 112.169 -171.391 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 49.09 -119.33 5.98 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 125.3 1.429 . . . . 0.0 113.155 171.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.64 -41.68 30.22 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.362 2.041 . . . . 0.0 112.307 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.9 tp -65.58 -36.6 84.23 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.203 1.365 . . . . 0.0 112.27 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -65.05 -37.17 86.7 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.496 1.118 . . . . 0.0 112.105 174.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.14 -43.69 70.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.753 0.821 . . . . 0.0 112.18 171.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.96 -42.14 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.986 1.714 . . . . 0.0 112.462 -174.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -98.85 -9.11 24.73 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.027 0.931 . . . . 0.0 113.35 -177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.276 0.1 OUTLIER 54.56 63.09 2.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.941 2.096 . . . . 0.0 113.16 -173.195 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 124.817 1.247 . . . . 0.0 112.56 175.101 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.4 mt 61.58 149.45 0.09 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 128.437 2.695 . . . . 0.0 115.534 -172.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -79.36 158.92 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.784 2.989 . . . . 0.0 112.063 174.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -54.33 -35.54 62.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.964 1.305 . . . . 0.0 113.676 -179.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -67.63 -23.38 65.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.2 mt -94.25 -45.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.597 1.159 . . . . 0.0 110.259 173.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -55.64 -31.96 62.78 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.439 0.696 . . . . 0.0 112.543 176.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 t -60.37 -39.5 87.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.106 0.962 . . . . 0.0 112.554 174.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.53 65.91 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.073 -1.017 . . . . 0.0 111.305 176.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.7 mm -58.58 -43.5 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.287 1.035 . . . . 0.0 110.861 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.41 89.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.007 0.923 . . . . 0.0 113.141 -172.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -41.24 97.23 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.222 0.919 . . . . 0.0 112.658 170.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.65 -33.08 74.86 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.4 -12.57 45.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.621 1.568 . . . . 0.0 113.862 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.73 74.6 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.102 0.858 . . . . 0.0 113.141 -171.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -132.55 70.04 1.47 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.615 1.966 . . . . 0.0 110.966 -167.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 t -125.95 128.99 48.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 110.294 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -157.21 167.62 29.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.782 0.833 . . . . 0.0 112.936 -175.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.32 -130.55 41.56 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.401 1.0 . . . . 0.0 113.245 170.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.94 -40.28 86.01 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.942 2.428 . . . . 0.0 113.272 175.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 30.9 tp -66.23 -36.86 84.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.635 1.107 . . . . 0.0 112.369 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -63.59 -40.12 96.14 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.427 1.091 . . . . 0.0 111.75 172.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.79 -39.19 84.08 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.653 0.781 . . . . 0.0 112.528 175.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.22 -46.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.4 1.48 . . . . 0.0 111.774 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -92.49 -13.69 29.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.09 1.356 . . . . 0.0 113.971 -170.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 mmtt 55.32 56.22 6.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.767 2.027 . . . . 0.0 112.08 -174.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 C--O 1.252 1.225 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.809 178.964 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.09 156.0 80.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.878 1.671 . . . . 0.0 111.038 178.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.71 153.82 73.03 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.895 2.397 . . . . 0.0 113.151 177.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -57.8 -36.54 72.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.104 0.962 . . . . 0.0 113.28 -179.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.84 -39.28 93.87 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.707 1.203 . . . . 0.0 112.423 175.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 -47.33 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.312 1.045 . . . . 0.0 109.787 178.221 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.62 -38.96 72.81 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.265 0.626 . . . . 0.0 111.684 175.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -61.79 -41.35 97.62 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 112.906 176.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.42 -39.34 94.24 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.334 -0.854 . . . . 0.0 111.356 178.879 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.5 mt -79.08 -36.18 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.78 1.632 . . . . 0.0 110.408 -174.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.22 96.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.256 1.023 . . . . 0.0 112.83 177.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' HE3' ' SG ' ' A' ' 25' ' ' CYS . 21.9 mmtp -57.61 -48.44 79.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.095 0.958 . . . . 0.0 111.817 169.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -66.38 -41.21 89.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.083 1.353 . . . . 0.0 112.92 -172.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -93.75 -12.78 28.41 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.107 1.363 . . . . 0.0 114.0 179.414 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.73 27.62 53.44 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.677 1.132 . . . . 0.0 112.918 179.477 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.45 15.34 23.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.439 2.296 . . . . 0.0 114.013 -166.102 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 t -84.03 119.13 24.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.525 1.13 . . . . 0.0 111.618 -175.489 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -159.9 169.65 23.07 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.191 1.396 . . . . 0.0 112.487 -174.534 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.4 -136.56 50.51 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 119.29 -0.728 . . . . 0.0 112.198 178.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.48 -35.96 97.15 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.925 2.417 . . . . 0.0 113.649 174.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.2 tp -65.54 -33.73 76.6 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.005 -1.059 . . . . 0.0 112.49 -176.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.77 -38.71 89.04 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.614 1.166 . . . . 0.0 112.634 172.232 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -71.39 -40.35 70.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.632 0.773 . . . . 0.0 112.349 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -69.36 -45.07 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.119 1.367 . . . . 0.0 112.145 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HE3' ' A' ' 12' ' ' LYS . 35.3 t -97.43 -5.14 36.83 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.021 1.729 . . . . 0.0 113.716 -171.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt 52.96 66.62 1.17 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.32 2.248 . . . . 0.0 112.232 -179.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.253 1.274 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.525 -176.941 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.37 140.63 87.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.201 1.001 . . . . 0.0 111.087 178.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.5 159.75 25.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.485 2.79 . . . . 0.0 112.146 178.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -57.08 -30.97 64.76 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -175.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -38.19 77.86 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.522 1.129 . . . . 0.0 112.455 178.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.63 -42.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.63 1.172 . . . . 0.0 110.11 175.279 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.98 -24.48 64.47 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.277 0.631 . . . . 0.0 112.666 173.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -30.63 69.76 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.832 1.253 . . . . 0.0 113.612 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.32 -44.83 35.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.901 0.858 . . . . 0.0 111.583 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.0 mt -73.92 -39.28 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.003 1.721 . . . . 0.0 111.164 -169.464 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.1 -46.79 88.43 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.021 1.329 . . . . 0.0 112.218 -175.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -69.0 -42.69 76.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.52 1.528 . . . . 0.0 111.637 176.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -41.08 95.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.879 1.272 . . . . 0.0 112.79 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -89.59 -9.61 49.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.288 1.435 . . . . 0.0 114.025 177.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.34 23.41 73.73 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.593 1.092 . . . . 0.0 114.793 -179.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.86 97.19 4.42 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.503 1.521 . . . . 0.0 110.913 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 t -139.55 119.14 13.08 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.001 1.72 . . . . 0.0 109.586 178.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -149.46 166.89 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.677 1.191 . . . . 0.0 112.703 -168.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.9 -132.62 52.64 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.285 0.945 . . . . 0.0 112.549 172.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -56.26 -37.84 96.07 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.713 2.276 . . . . 0.0 113.388 174.095 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -65.75 -42.03 91.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.141 -0.974 . . . . 0.0 112.326 -174.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -52.88 -42.07 64.95 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.134 1.774 . . . . 0.0 111.545 174.617 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.44 -25.29 57.34 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.983 1.713 . . . . 0.0 113.193 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.8 -40.44 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.647 1.179 . . . . 0.0 109.464 -175.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.2 m -102.01 -6.69 23.1 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.053 1.741 . . . . 0.0 114.456 -169.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt 50.11 48.62 21.79 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.303 1.841 . . . . 0.0 112.012 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.75 -176.456 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.81 151.81 93.23 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.346 1.059 . . . . 0.0 111.754 178.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.84 159.01 45.92 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.683 2.922 . . . . 0.0 111.834 174.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -56.98 -29.54 63.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -175.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.23 -24.78 63.14 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.594 1.158 . . . . 0.0 113.905 176.198 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.09 -41.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.804 1.242 . . . . 0.0 110.417 172.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.68 -27.34 64.72 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.566 -0.709 . . . . 0.0 112.627 173.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.1 t -59.23 -38.44 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.911 172.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.28 -43.05 74.66 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.336 -0.852 . . . . 0.0 110.716 176.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -60.77 -49.01 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 110.837 176.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.43 -48.2 79.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.858 1.263 . . . . 0.0 112.451 -174.026 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -77.08 -27.97 54.4 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -75.05 -37.01 61.79 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.581 1.082 . . . . 0.0 113.122 174.25 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.04 -14.15 54.43 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.979 1.312 . . . . 0.0 113.131 174.377 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.35 25.04 71.62 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.558 1.075 . . . . 0.0 114.159 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -130.14 101.57 5.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.533 1.533 . . . . 0.0 110.385 -178.867 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 t -150.48 124.63 9.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.175 1.39 . . . . 0.0 110.543 -176.192 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -149.25 161.78 41.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.742 1.217 . . . . 0.0 113.07 -174.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.27 -116.56 7.06 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.987 1.279 . . . . 0.0 113.477 169.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.64 -41.8 23.47 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.172 1.915 . . . . 0.0 112.046 178.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -40.21 96.09 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.971 -1.081 . . . . 0.0 111.188 -178.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -58.51 -46.06 87.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.787 2.035 . . . . 0.0 111.385 175.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.9 tp -68.42 -40.45 81.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.439 1.096 . . . . 0.0 112.763 177.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -69.26 -45.11 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.168 1.387 . . . . 0.0 111.951 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.9 t -102.65 -9.31 20.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.118 1.367 . . . . 0.0 114.228 -165.003 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp 53.05 53.19 12.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.874 2.07 . . . . 0.0 112.146 -178.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 CA-C-N 112.582 -2.099 . . . . 0.0 113.011 -179.297 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.3 138.55 86.79 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.222 1.009 . . . . 0.0 111.215 179.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.1 155.96 42.49 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.957 2.438 . . . . 0.0 111.008 172.212 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.33 -37.37 64.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.9 1.28 . . . . 0.0 113.986 -172.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -73.45 -29.32 62.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.401 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.62 -46.99 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.935 0.894 . . . . 0.0 109.884 166.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.9 tp -60.88 -29.31 69.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.217 1.007 . . . . 0.0 112.74 -175.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -58.76 -32.26 69.1 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.26 75.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.507 -0.746 . . . . 0.0 111.788 174.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.48 -43.46 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 126.058 1.743 . . . . 0.0 109.163 -175.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.19 -50.88 27.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.175 1.79 . . . . 0.0 112.569 173.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -88.02 -29.22 20.87 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.127 1.771 . . . . 0.0 113.023 -165.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.33 -35.04 41.65 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.032 0.933 . . . . 0.0 113.461 173.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.04 -13.74 30.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.756 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.37 46.39 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.89 178.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -101.43 8.55 42.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.664 2.785 . . . . 0.0 113.225 -173.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.2 t -79.13 110.45 14.4 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.399 1.08 . . . . 0.0 111.423 -176.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.93 173.1 17.0 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.196 1.798 . . . . 0.0 111.466 -177.332 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.93 -138.92 48.62 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-O 119.08 -0.844 . . . . 0.0 111.583 -176.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.29 -38.4 95.17 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.936 2.424 . . . . 0.0 113.69 176.616 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -40.12 80.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.187 0.903 . . . . 0.0 112.283 -173.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.0 -35.09 79.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.914 1.286 . . . . 0.0 112.617 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.21 -38.65 24.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.818 1.247 . . . . 0.0 112.55 175.475 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.53 -37.46 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.065 1.746 . . . . 0.0 111.921 -177.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.6 t -120.78 7.23 10.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.081 1.352 . . . . 0.0 113.365 -172.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? 49.13 68.78 0.66 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.556 2.343 . . . . 0.0 113.153 175.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.449 1.099 . . . . 0.0 111.686 -179.662 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.09 146.19 86.92 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.087 0.955 . . . . 0.0 112.081 178.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.98 154.53 57.95 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.279 2.653 . . . . 0.0 110.753 171.15 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -53.77 -36.75 62.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.698 1.199 . . . . 0.0 113.818 -172.594 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -61.25 -35.98 78.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.848 1.659 . . . . 0.0 113.164 177.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.2 mt -91.71 -43.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.462 1.105 . . . . 0.0 110.47 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.76 -34.22 65.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.92 1.288 . . . . 0.0 111.647 177.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.89 -38.44 85.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.266 1.027 . . . . 0.0 112.888 174.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -37.55 79.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.032 -1.043 . . . . 0.0 111.082 178.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.0 -45.91 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.966 0.906 . . . . 0.0 110.277 173.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.11 88.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.01 0.924 . . . . 0.0 112.361 177.126 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -64.25 -43.18 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.477 1.511 . . . . 0.0 112.469 177.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -77.53 -40.53 42.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.663 1.185 . . . . 0.0 113.846 -176.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.95 -6.71 53.7 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.657 1.183 . . . . 0.0 113.698 -176.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 24.92 62.76 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.16 0.886 . . . . 0.0 113.274 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 0.85 56.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.941 2.096 . . . . 0.0 113.612 -175.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.9 t -79.87 84.14 5.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.275 1.03 . . . . 0.0 111.99 -177.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -145.62 168.82 19.74 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.706 2.003 . . . . 0.0 112.24 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.25 -138.88 48.43 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.207 -170.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -57.11 -31.84 91.57 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.064 2.509 . . . . 0.0 113.912 174.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.22 -37.08 81.75 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.184 -0.948 . . . . 0.0 112.138 -176.456 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -60.35 -28.39 68.13 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.337 1.455 . . . . 0.0 113.327 174.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tt -80.43 -49.75 11.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.252 1.021 . . . . 0.0 111.227 170.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.18 -40.99 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.14 1.376 . . . . 0.0 112.909 -175.497 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.8 t -102.04 -7.57 22.21 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.24 1.816 . . . . 0.0 112.972 -176.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? 56.57 84.36 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.033 2.533 . . . . 0.0 112.976 179.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.3 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.767 1.627 . . . . 0.0 112.908 -174.265 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.14 145.2 85.67 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.048 0.939 . . . . 0.0 112.058 178.308 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.55 154.12 54.99 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.271 2.647 . . . . 0.0 110.707 169.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.78 -38.62 49.18 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.206 1.403 . . . . 0.0 114.164 -173.774 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -68.29 -20.24 64.75 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.6 mt -102.18 -42.97 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.012 1.325 . . . . 0.0 110.326 173.281 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.78 -29.53 62.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.935 1.294 . . . . 0.0 112.542 178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -63.01 -29.34 70.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.202 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.52 75.69 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.047 -1.033 . . . . 0.0 111.507 176.145 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.34 -45.98 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.997 1.319 . . . . 0.0 110.056 171.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -41.45 83.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.902 1.281 . . . . 0.0 112.554 -177.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -79.38 -29.21 42.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.99 0.916 . . . . 0.0 113.163 178.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -68.89 -40.15 79.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.522 1.129 . . . . 0.0 112.258 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -87.67 -12.97 43.86 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.959 1.303 . . . . 0.0 114.244 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 123.95 0.786 . . . . 0.0 113.684 -169.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.09 -8.95 58.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.709 2.004 . . . . 0.0 113.486 -176.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.6 t -69.1 99.7 1.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.396 -0.815 . . . . 0.0 111.517 179.016 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -143.73 162.37 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.004 2.122 . . . . 0.0 109.889 -176.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.35 -127.02 40.89 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.882 -0.954 . . . . 0.0 112.7 176.27 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.43 -40.92 81.38 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.061 2.507 . . . . 0.0 113.948 -179.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -38.46 91.1 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.526 1.057 . . . . 0.0 111.42 -177.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -69.1 -38.43 78.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.966 1.306 . . . . 0.0 111.669 175.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.1 tp -67.13 -38.08 84.95 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.633 0.773 . . . . 0.0 112.282 174.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.23 -47.2 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.529 1.532 . . . . 0.0 111.802 178.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.08 -7.45 18.0 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.11 47.22 17.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.88 2.072 . . . . 0.0 112.615 178.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 112.834 -1.985 . . . . 0.0 113.115 178.847 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.46 147.61 66.6 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.88 1.672 . . . . 0.0 110.738 178.743 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.79 152.94 42.5 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.004 2.469 . . . . 0.0 111.142 177.233 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -53.93 -34.23 59.0 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.718 1.207 . . . . 0.0 114.039 -173.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -68.82 -29.09 67.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 179.214 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.75 -48.34 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.629 1.172 . . . . 0.0 110.212 166.457 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.2 -33.51 73.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.87 0.868 . . . . 0.0 112.308 -172.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -56.61 -41.67 77.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.616 176.907 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.55 98.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.949 0.881 . . . . 0.0 111.468 178.235 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.28 -41.49 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.835 1.654 . . . . 0.0 109.783 -172.815 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.57 80.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.653 1.181 . . . . 0.0 112.853 -175.922 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -85.39 -17.51 36.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 179.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.21 -38.17 72.05 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 164.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -91.41 -20.27 21.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.762 1.225 . . . . 0.0 114.208 179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.96 23.08 36.39 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.768 1.175 . . . . 0.0 113.498 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -102.61 8.04 39.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.071 2.549 . . . . 0.0 113.969 -173.121 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 t -83.09 119.19 24.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.063 1.345 . . . . 0.0 111.609 -175.094 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -160.69 171.12 19.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.008 1.323 . . . . 0.0 112.624 -174.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.01 -138.08 49.07 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 119.176 -0.791 . . . . 0.0 111.95 -179.183 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.68 -34.68 96.44 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.007 2.471 . . . . 0.0 113.778 174.349 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.4 tp -64.44 -34.57 78.51 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.183 -0.948 . . . . 0.0 112.568 -175.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -60.09 -40.28 89.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.502 1.121 . . . . 0.0 112.536 172.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.99 -39.91 68.94 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.747 0.819 . . . . 0.0 112.467 175.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.28 -44.64 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.107 1.363 . . . . 0.0 111.846 177.585 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.1 t -100.86 -7.84 23.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 114.177 -169.25 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 54.89 50.95 14.49 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.222 2.209 . . . . 0.0 112.305 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.1 m . . . . . 0 C--O 1.254 1.298 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.01 -178.583 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.43 153.74 85.83 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.121 0.969 . . . . 0.0 111.941 177.725 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.59 152.42 77.87 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.076 2.517 . . . . 0.0 113.062 175.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -61.05 -31.65 71.29 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -63.08 -41.7 99.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 112.213 173.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.59 -44.29 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.305 1.042 . . . . 0.0 109.985 177.78 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.27 -32.63 71.36 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.506 -0.746 . . . . 0.0 112.02 174.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -70.46 -29.27 65.79 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 173.314 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.08 85.41 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.338 -0.851 . . . . 0.0 110.205 175.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.8 mm -62.14 -52.87 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.826 0.85 . . . . 0.0 110.205 168.759 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.05 72.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 112.431 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.59 -31.46 57.52 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.248 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -74.62 -35.68 62.92 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.464 1.029 . . . . 0.0 113.197 175.337 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -81.05 -11.7 59.47 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.988 1.315 . . . . 0.0 113.013 173.095 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.85 22.43 74.55 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.748 1.165 . . . . 0.0 114.398 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.64 95.32 3.7 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.268 1.427 . . . . 0.0 110.925 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -134.82 122.13 21.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.754 1.621 . . . . 0.0 109.095 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -151.89 169.99 20.93 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.918 1.287 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.9 -122.33 16.55 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.698 1.142 . . . . 0.0 112.944 173.361 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.37 -39.91 34.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.547 2.165 . . . . 0.0 112.641 -178.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -40.26 96.9 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.946 1.248 . . . . 0.0 111.207 -178.38 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -68.49 -38.84 81.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.071 1.348 . . . . 0.0 111.916 175.714 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.42 -37.84 86.1 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.54 0.736 . . . . 0.0 112.278 174.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -71.28 -45.95 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 111.836 178.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -104.96 -11.23 16.77 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -167.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt 57.0 47.04 18.32 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.519 1.927 . . . . 0.0 112.368 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.708 2.003 . . . . 0.0 112.727 176.308 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.97 141.93 78.94 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.979 0.912 . . . . 0.0 111.561 178.329 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.67 151.54 79.73 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.01 2.473 . . . . 0.0 111.791 169.675 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -55.47 -36.55 66.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -173.925 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -61.97 -50.5 71.86 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.87 1.268 . . . . 0.0 112.294 176.116 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.85 -44.74 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.401 1.08 . . . . 0.0 110.136 178.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.88 -32.51 70.79 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.369 1.067 . . . . 0.0 112.001 177.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.5 t -67.29 -30.52 70.4 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 174.717 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.01 -40.79 87.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.162 -0.961 . . . . 0.0 110.388 175.372 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.71 -49.06 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.085 0.954 . . . . 0.0 110.324 171.192 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.05 76.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.333 1.053 . . . . 0.0 112.757 -177.244 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -82.26 -31.21 30.26 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.959 0.903 . . . . 0.0 113.311 179.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -70.95 -36.71 72.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.025 0.93 . . . . 0.0 112.967 173.468 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -86.66 -11.66 50.66 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.008 1.323 . . . . 0.0 113.657 176.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.65 24.03 77.24 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.279 0.942 . . . . 0.0 113.787 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -99.1 -2.15 37.75 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.722 2.009 . . . . 0.0 113.644 -173.541 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.6 t -69.8 110.05 4.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.088 -1.007 . . . . 0.0 111.689 -178.267 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -143.81 164.93 29.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.541 1.936 . . . . 0.0 110.749 -175.362 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 47.79 -114.72 1.9 Allowed Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.188 1.375 . . . . 0.0 113.592 170.49 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.82 -43.64 19.64 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.579 2.186 . . . . 0.0 112.656 -179.157 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -39.37 93.69 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.244 1.384 . . . . 0.0 111.337 -177.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -61.65 -47.5 85.08 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.382 1.473 . . . . 0.0 110.777 175.115 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.95 -38.56 91.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.528 1.131 . . . . 0.0 113.207 176.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.45 -43.15 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.513 1.525 . . . . 0.0 112.555 -176.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -105.27 -20.94 13.35 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.154 0.982 . . . . 0.0 113.13 -168.618 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.331 0.0 OUTLIER 61.82 119.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.469 2.708 . . . . 0.0 112.28 -155.757 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.68 1.592 . . . . 0.0 111.386 175.863 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.13 149.59 89.58 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.982 0.913 . . . . 0.0 112.42 178.15 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.72 142.39 91.62 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.501 2.801 . . . . 0.0 111.48 165.097 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -34.63 72.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -69.12 -24.04 64.06 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.76 -45.73 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.32 1.048 . . . . 0.0 109.749 171.618 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.3 tp -57.69 -29.52 64.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 112.349 177.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 m -56.78 -33.86 67.05 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.782 1.233 . . . . 0.0 113.74 175.413 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -22.61 67.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 176.19 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.1 mt -103.54 -48.32 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.581 1.553 . . . . 0.0 108.664 -173.819 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.65 -43.09 84.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.103 1.361 . . . . 0.0 112.834 179.575 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -87.43 -27.52 22.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.3 -36.88 53.74 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.906 1.23 . . . . 0.0 113.725 172.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -87.25 -22.39 25.24 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.825 0.85 . . . . 0.0 113.282 177.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.0 22.58 41.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.389 0.995 . . . . 0.0 113.181 177.575 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -89.07 -6.07 57.39 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.313 2.245 . . . . 0.0 113.969 -174.72 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 t -72.13 111.93 7.78 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.705 1.202 . . . . 0.0 112.77 -174.054 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -147.85 167.13 25.57 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.495 1.518 . . . . 0.0 112.772 -175.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.35 -123.88 34.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.563 1.078 . . . . 0.0 112.275 173.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.35 -37.17 31.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 CA-C-N 119.886 1.843 . . . . 0.0 112.038 175.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.48 -34.42 78.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.925 -1.11 . . . . 0.0 112.386 -176.165 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -56.15 -38.91 71.51 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.784 1.633 . . . . 0.0 112.12 173.469 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.63 -52.94 9.41 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 111.873 171.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.48 -32.12 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.902 1.681 . . . . 0.0 113.641 -171.762 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -104.01 -6.34 21.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.068 1.747 . . . . 0.0 112.931 -179.096 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.21 75.05 0.12 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 128.287 2.635 . . . . 0.0 112.665 -172.194 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.181 1.392 . . . . 0.0 112.235 -178.888 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.45 157.34 84.66 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.086 0.954 . . . . 0.0 112.444 177.816 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -56.17 147.12 67.36 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.91 3.073 . . . . 0.0 113.431 171.938 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -58.18 -35.62 71.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.128 0.971 . . . . 0.0 113.17 -178.475 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -68.41 -24.34 64.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -87.07 -44.43 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.696 1.198 . . . . 0.0 110.357 174.519 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -57.04 -33.46 67.24 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.285 0.634 . . . . 0.0 111.953 172.649 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.93 -33.91 76.33 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.227 1.011 . . . . 0.0 113.049 176.23 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.12 -24.27 63.16 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.294 -0.879 . . . . 0.0 112.267 177.745 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.7 mm -79.74 -50.64 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 169.782 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.93 74.64 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.251 1.42 . . . . 0.0 112.754 -174.312 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -69.96 -31.4 69.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.341 1.856 . . . . 0.0 113.66 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -75.92 -38.7 57.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.323 1.049 . . . . 0.0 112.881 175.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.52 -22.64 30.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.812 1.245 . . . . 0.0 114.224 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.03 40.84 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.588 0.631 . . . . 0.0 112.063 -169.931 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -102.34 -9.54 20.25 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.159 2.184 . . . . 0.0 112.501 -176.991 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.19 85.15 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.857 2.063 . . . . 0.0 112.072 172.2 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.31 161.81 34.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.723 2.009 . . . . 0.0 111.324 -174.202 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.83 -129.34 48.97 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.595 -175.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.05 -30.0 47.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.312 2.008 . . . . 0.0 112.846 177.557 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -67.92 -27.95 67.07 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.903 -1.123 . . . . 0.0 112.474 -179.183 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -59.97 -43.01 95.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.543 1.137 . . . . 0.0 111.66 170.755 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.35 -32.47 62.79 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.814 1.246 . . . . 0.0 112.636 178.126 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -72.12 -42.09 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.175 0.99 . . . . 0.0 111.871 174.868 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.7 t -98.97 -11.08 21.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.019 1.328 . . . . 0.0 113.936 -169.358 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.3 72.81 0.51 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.489 2.316 . . . . 0.0 111.762 -176.396 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.253 1.241 0 CA-C-N 113.144 -1.844 . . . . 0.0 111.955 172.497 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 145.41 85.37 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.114 0.965 . . . . 0.0 112.148 178.241 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.43 154.2 60.73 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.068 2.512 . . . . 0.0 110.413 167.244 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -52.93 -46.41 68.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.907 0.883 . . . . 0.0 113.331 -170.162 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.96 -23.47 67.35 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.005 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.98 -44.89 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.262 1.025 . . . . 0.0 110.222 173.75 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.7 tp -55.27 -34.29 63.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.875 0.87 . . . . 0.0 112.04 174.772 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 68.6 m -63.39 -29.98 71.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.559 1.144 . . . . 0.0 113.098 176.975 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.07 -45.27 58.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.98 0.809 . . . . 0.0 110.412 175.179 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.55 -46.0 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.133 0.973 . . . . 0.0 110.752 176.177 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.33 73.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.824 1.25 . . . . 0.0 113.087 -178.37 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -90.49 -29.33 17.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.948 1.299 . . . . 0.0 113.434 -179.77 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -69.88 -37.15 75.96 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.404 1.081 . . . . 0.0 112.629 172.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -86.83 -15.5 38.97 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.547 1.139 . . . . 0.0 113.698 175.081 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.32 20.0 77.9 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.046 0.831 . . . . 0.0 113.917 -173.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -75.69 -28.81 58.79 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.42 1.888 . . . . 0.0 113.53 -177.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.62 116.53 3.76 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.227 1.811 . . . . 0.0 113.956 -168.754 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -148.44 165.36 31.37 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.099 1.76 . . . . 0.0 111.952 -177.436 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.82 -129.33 41.65 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.391 0.996 . . . . 0.0 113.416 169.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -55.75 -36.19 94.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.823 176.723 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.2 tp -70.35 -39.07 74.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.305 0.957 . . . . 0.0 112.123 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -58.32 -37.46 75.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.743 1.217 . . . . 0.0 111.224 171.658 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -16.86 63.41 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.985 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.5 t -97.52 -42.85 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.902 1.281 . . . . 0.0 109.703 179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.6 m -102.29 -3.36 27.35 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.114 1.766 . . . . 0.0 114.125 -166.341 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt 51.93 58.59 5.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.427 2.291 . . . . 0.0 112.136 177.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.253 1.258 0 CA-C-N 112.569 -2.105 . . . . 0.0 112.934 -173.757 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.26 144.61 84.63 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.997 0.919 . . . . 0.0 111.976 178.238 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.53 155.41 54.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.444 2.763 . . . . 0.0 110.908 172.314 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -49.96 -41.29 46.31 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.219 1.408 . . . . 0.0 114.05 -173.814 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -67.83 -19.95 65.11 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.83 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.2 mt -101.2 -44.92 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.988 1.315 . . . . 0.0 110.538 173.619 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.6 -35.63 70.69 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 111.5 179.628 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.91 -27.88 67.85 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.127 -0.983 . . . . 0.0 113.084 176.331 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.63 -19.66 61.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.815 -1.178 . . . . 0.0 112.207 175.058 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.2 -47.04 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.679 1.192 . . . . 0.0 109.605 165.88 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.38 72.92 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.309 1.044 . . . . 0.0 112.408 -178.509 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -77.0 -28.5 55.09 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.433 1.093 . . . . 0.0 113.654 -179.754 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.52 -41.24 66.09 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.704 0.802 . . . . 0.0 112.835 171.839 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -81.11 -22.46 39.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 179.814 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.57 14.68 67.59 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.594 1.092 . . . . 0.0 112.817 -173.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -83.92 -3.5 57.99 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.19 2.196 . . . . 0.0 113.869 -177.459 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -78.38 84.13 4.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.335 1.065 . . . . 0.0 111.407 178.068 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -134.03 162.66 31.47 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.24 2.216 . . . . 0.0 110.521 179.164 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.87 -126.48 40.19 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 118.891 -0.95 . . . . 0.0 112.678 176.985 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.88 -39.48 90.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.807 178.432 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -38.98 92.91 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.059 -1.026 . . . . 0.0 111.743 -177.769 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -66.84 -39.52 87.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.463 1.505 . . . . 0.0 111.293 175.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.72 -42.64 90.83 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.776 0.83 . . . . 0.0 111.52 174.775 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -66.17 -46.05 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.533 1.533 . . . . 0.0 112.267 179.401 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.1 t -105.81 -10.46 16.69 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -168.45 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp 56.27 59.44 3.67 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.035 2.134 . . . . 0.0 112.354 -177.495 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 C--O 1.252 1.23 0 CA-C-N 112.857 -1.974 . . . . 0.0 112.508 -178.439 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.6 mp 62.32 149.78 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 128.206 2.602 . . . . 0.0 114.664 -173.041 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.48 149.96 45.3 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.008 2.472 . . . . 0.0 110.615 172.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -55.95 -34.6 65.82 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.467 1.107 . . . . 0.0 113.837 -172.079 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -66.85 -21.13 66.03 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 178.36 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -100.96 -45.13 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.025 1.33 . . . . 0.0 110.294 172.974 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.32 -28.94 65.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.012 1.325 . . . . 0.0 112.168 -178.752 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -55.38 -35.0 64.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 113.661 172.485 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.27 73.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.949 0.795 . . . . 0.0 111.895 175.417 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.5 mt -85.96 -44.05 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.873 1.669 . . . . 0.0 109.122 -175.239 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 17' ' ' CYS . . . -51.99 -50.42 61.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.011 1.325 . . . . 0.0 111.768 175.701 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.33 -30.54 66.33 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.794 2.038 . . . . 0.0 114.545 -178.718 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.51 -37.06 44.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.091 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -88.68 -13.3 40.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.869 1.268 . . . . 0.0 114.189 -178.361 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.33 33.93 68.68 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.65 0.659 . . . . 0.0 112.4 -170.814 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -104.05 -0.65 28.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.359 1.864 . . . . 0.0 111.739 -178.119 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB3' ' HB1' ' A' ' 11' ' ' ALA . 5.2 p -74.41 98.59 3.32 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.346 1.858 . . . . 0.0 110.726 170.305 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -147.3 165.02 31.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.816 1.647 . . . . 0.0 111.952 -177.957 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.63 -132.21 51.7 Favored Glycine 0 CA--C 1.54 1.641 0 CA-C-O 118.778 -1.012 . . . . 0.0 111.589 -174.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.93 -29.96 48.97 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.417 2.078 . . . . 0.0 113.052 178.744 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.28 -30.81 71.72 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.886 -1.134 . . . . 0.0 112.315 179.885 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -58.82 -40.78 85.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.04 0.936 . . . . 0.0 111.719 172.998 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 tt -76.69 -31.28 57.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.803 1.641 . . . . 0.0 112.901 176.707 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.9 t -71.48 -37.41 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 120.907 -1.12 . . . . 0.0 111.734 172.923 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.3 t -103.58 -14.11 16.29 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.856 1.262 . . . . 0.0 113.871 -167.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? 57.43 67.77 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.206 1.803 . . . . 0.0 112.488 -174.642 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.252 1.208 0 C-N-CA 126.375 1.87 . . . . 0.0 111.86 167.926 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.9 mp -70.13 144.2 92.28 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 111.619 178.901 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.95 153.81 52.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.144 2.562 . . . . 0.0 110.615 169.181 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -56.3 -32.37 64.53 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.576 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -68.16 -21.29 64.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.705 1.202 . . . . 0.0 114.076 178.809 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 63.6 mt -99.74 -48.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.965 1.306 . . . . 0.0 110.148 172.385 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.57 -31.68 64.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.503 1.121 . . . . 0.0 112.626 -178.053 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -61.03 -36.39 79.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.012 0.925 . . . . 0.0 113.177 177.182 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.18 75.43 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 111.104 176.712 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.02 -45.93 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.264 1.025 . . . . 0.0 110.586 176.389 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.84 88.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.829 1.252 . . . . 0.0 112.959 -175.82 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.15 -22.27 36.18 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.761 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -77.55 -38.07 49.36 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.279 1.032 . . . . 0.0 112.792 170.69 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -87.36 -16.7 34.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.277 1.431 . . . . 0.0 113.916 178.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.071 0.843 . . . . 0.0 113.486 -173.944 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -102.99 5.88 38.52 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.605 1.962 . . . . 0.0 113.412 -171.728 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 t -81.93 121.56 26.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.308 1.443 . . . . 0.0 111.857 -174.96 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -160.77 170.92 19.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.35 1.46 . . . . 0.0 112.626 -176.645 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.93 -130.77 51.34 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.295 178.387 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.88 -32.04 46.36 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.112 1.875 . . . . 0.0 112.566 177.977 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.47 -35.11 79.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.659 1.118 . . . . 0.0 112.053 -178.306 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -62.08 -38.12 87.61 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.665 1.186 . . . . 0.0 112.573 173.326 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -68.77 -43.38 75.88 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.722 0.809 . . . . 0.0 111.764 173.661 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.11 -43.33 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -178.781 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -98.1 -7.59 29.32 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.014 1.726 . . . . 0.0 113.918 -171.866 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 55.02 57.79 5.3 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.44 2.296 . . . . 0.0 112.017 178.847 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.251 1.163 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.686 -176.563 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.15 145.56 86.05 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.008 0.923 . . . . 0.0 112.148 178.447 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.93 156.17 52.62 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.476 2.784 . . . . 0.0 110.907 172.206 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -53.75 -35.6 61.42 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.398 1.079 . . . . 0.0 113.487 -175.327 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -66.27 -17.47 64.77 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.371 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.8 mt -106.99 -47.8 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.219 1.407 . . . . 0.0 110.303 172.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.74 -31.58 66.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.447 1.499 . . . . 0.0 112.221 -177.771 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -57.47 -42.03 81.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.189 0.996 . . . . 0.0 112.486 174.023 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.21 88.63 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.384 -0.823 . . . . 0.0 111.111 179.806 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.58 -47.79 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.99 0.916 . . . . 0.0 110.408 174.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.95 80.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -170.818 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -94.38 -16.83 23.12 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 179.556 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.12 -36.47 64.19 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.006 0.821 . . . . 0.0 112.563 164.578 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.69 -15.03 43.64 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.861 1.265 . . . . 0.0 113.521 175.157 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.93 19.19 79.03 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.462 1.029 . . . . 0.0 114.765 179.907 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -86.62 -13.72 44.82 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.89 1.676 . . . . 0.0 113.506 -178.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 t -66.35 110.87 3.24 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.161 1.384 . . . . 0.0 113.111 -172.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -146.1 166.86 24.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.161 1.784 . . . . 0.0 112.135 -176.735 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.87 -123.64 27.32 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.809 1.195 . . . . 0.0 112.902 173.867 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -64.49 -34.89 51.62 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.265 1.977 . . . . 0.0 112.435 178.182 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -38.46 91.04 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.837 -1.164 . . . . 0.0 111.44 -179.603 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -61.22 -36.25 79.42 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.003 1.321 . . . . 0.0 112.048 175.105 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.95 -46.71 64.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.945 0.898 . . . . 0.0 111.971 171.434 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.3 t -66.25 -42.38 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.343 1.457 . . . . 0.0 112.733 -176.935 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.6 t -101.84 -7.95 22.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 113.383 -171.995 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 54.78 65.98 1.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 127.386 2.275 . . . . 0.0 112.37 179.966 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.457 1.503 . . . . 0.0 112.752 -172.245 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt 61.71 147.29 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 128.425 2.69 . . . . 0.0 115.318 -173.008 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 154.1 42.27 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.451 2.768 . . . . 0.0 111.236 174.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -50.65 -43.72 57.28 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.964 1.305 . . . . 0.0 114.333 -170.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.33 -16.01 64.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -178.621 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.9 mt -101.85 -48.83 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.193 1.397 . . . . 0.0 110.156 172.78 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.17 -32.56 68.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.969 1.308 . . . . 0.0 112.013 -178.617 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -60.83 -35.42 76.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.185 0.994 . . . . 0.0 113.14 175.21 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.94 82.89 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.103 -0.998 . . . . 0.0 110.731 175.729 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.55 -47.06 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 174.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.11 -43.9 78.56 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.86 1.264 . . . . 0.0 112.121 -178.51 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -82.33 -30.32 30.51 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -70.5 -36.45 73.8 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.549 1.068 . . . . 0.0 113.005 173.644 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -83.71 -16.23 45.71 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.745 1.218 . . . . 0.0 113.304 173.634 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.3 19.0 75.57 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.487 1.041 . . . . 0.0 113.833 -173.519 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -103.52 69.1 0.97 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.451 1.9 . . . . 0.0 110.139 -174.122 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 t -146.05 118.76 8.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.428 1.091 . . . . 0.0 111.997 -174.333 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -146.26 168.37 21.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.617 1.967 . . . . 0.0 110.994 177.53 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.79 -126.52 38.24 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.262 0.934 . . . . 0.0 113.409 169.455 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.93 -40.14 86.88 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.97 2.447 . . . . 0.0 113.539 177.172 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -41.31 97.45 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.362 0.983 . . . . 0.0 111.016 -179.672 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.99 -39.96 95.31 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.234 1.414 . . . . 0.0 111.57 176.469 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.09 -42.99 96.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.985 0.914 . . . . 0.0 111.996 173.677 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.76 -44.01 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.366 1.467 . . . . 0.0 112.343 -179.771 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -104.84 -11.49 16.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 -165.526 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp 55.33 60.93 3.11 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.99 2.116 . . . . 0.0 111.903 -177.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 64.1 m . . . . . 0 C--O 1.251 1.181 0 CA-C-N 112.546 -2.116 . . . . 0.0 112.449 -179.405 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 121.695 0.608 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.78 150.25 72.19 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 129.181 2.993 . . . . 0.0 112.471 -1.377 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.9 154.37 53.3 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.329 2.686 . . . . 0.0 110.921 172.556 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -53.79 -36.97 63.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.813 1.245 . . . . 0.0 113.674 -173.453 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -67.31 -21.18 65.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.665 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.0 mt -99.93 -45.79 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.91 1.284 . . . . 0.0 110.187 172.986 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.32 -28.64 66.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 112.677 -178.295 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.6 t -60.47 -37.88 82.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.53 1.132 . . . . 0.0 112.844 172.598 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -43.68 75.97 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.969 -1.082 . . . . 0.0 110.781 176.523 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.5 mm -64.46 -41.47 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.621 1.168 . . . . 0.0 111.435 178.382 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.14 -38.14 73.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.633 1.173 . . . . 0.0 112.231 178.023 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -82.64 -34.33 27.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.821 1.248 . . . . 0.0 112.696 177.042 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -60.85 -42.12 97.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.546 1.539 . . . . 0.0 112.936 173.736 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -90.7 -12.76 35.71 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.476 1.51 . . . . 0.0 113.792 179.693 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.84 23.56 76.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.014 0.816 . . . . 0.0 113.731 -172.803 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -94.66 -0.68 54.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.495 1.918 . . . . 0.0 113.461 -174.315 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.81 100.87 0.75 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.828 1.251 . . . . 0.0 112.483 -174.979 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -144.26 165.26 28.38 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.339 1.856 . . . . 0.0 111.746 -172.287 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.17 -125.8 34.58 Favored Glycine 0 CA--C 1.539 1.569 0 CA-C-O 118.799 -1.0 . . . . 0.0 112.26 177.364 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -65.33 -34.38 44.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.163 1.909 . . . . 0.0 112.572 178.024 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -37.86 88.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.729 1.149 . . . . 0.0 111.546 -177.8 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -60.68 -38.03 83.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.959 1.304 . . . . 0.0 112.209 175.053 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.73 -42.62 60.9 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 112.61 174.1 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.8 t -64.85 -40.14 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.7 1.6 . . . . 0.0 112.342 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -103.41 -8.43 20.21 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.116 1.766 . . . . 0.0 112.715 -171.697 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 53.94 63.95 2.0 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.782 2.433 . . . . 0.0 112.615 -178.115 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.08 1.352 . . . . 0.0 112.33 -175.936 . . . . . . . . 0 0 . 1 stop_ save_